var title_f10_36_10816="Necrobiosis lipoidica";
var content_f10_36_10816=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74010&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74010&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrobiosis lipoidica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the thin, yellow, atrophic plaque with telangiectasia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10816=[""].join("\n");
var outline_f10_36_10816=null;
var title_f10_36_10817="Borderline tuberculoid leprosy";
var content_f10_36_10817=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F65926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F65926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Borderline tuberculoid leprosy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 364px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lesions remain macular and hypopigmented but are more numerous than in tuberculoid disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from McDougall AC, Yuasa Y. A New Atlas of leprosy, Sasakawa Memorial Health Foundation, Tokyo, 2000, and Guinto RS, Abalos RM, Cellopna RV, Fajardo TT. An Atlas of Leprosy, Sasakawa Memorial Health Foundation, Tokyo, 1983.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10817=[""].join("\n");
var outline_f10_36_10817=null;
var title_f10_36_10818="Irreversible sickle cell TEM";
var content_f10_36_10818=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F61255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F61255&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Sickled red blood cell by transmission electron micrography (TEM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 162px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transmission electron micrograph of a red blood cell from a patient with homozygous sickle cell disease. Strands of polymerized deoxygenated hemoglobin S running lengthwise through the cell are just discernible at this magnification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stanley L Schrier, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10818=[""].join("\n");
var outline_f10_36_10818=null;
var title_f10_36_10819="Isoxsuprine: Drug information";
var content_f10_36_10819=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Isoxsuprine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F185282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vasodilator",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F185258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Peripheral vascular disease or symptoms of cerebrovascular insufficiency:",
"     </b>",
"     Oral: 10-20 mg 3-4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F185259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. Start with lower dose due to potential hypotension.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16160054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16160055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F185244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 10 mg, 20 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F185232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F185245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of peripheral vascular diseases, such as arteriosclerosis obliterans, thromboangiitis obliterans (Buerger&rsquo;s disease), and Raynaud's disease; relief of symptoms associated with cerebrovascular insufficiency",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     More appropriate therapies (medical or surgical) should be considered; efficacy of isoxsuprine in the treatment of these conditions has not been well established.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F185286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Vasodilan may be confused with Vasocidin&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - high; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F185280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, hypotension, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distress, nausea, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F185248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Presence of arterial bleeding; use immediately postpartum",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9958836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Elderly: Avoid use in this age group due to lack of efficacy (Beers Criteria).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F185239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13765949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Isoxsuprine crosses the placenta. Adverse effects (eg, hypocalcemia, hypoglycemia, hypotension, and ileus) requiring treatment have been observed in infants born to mothers who received isoxsuprine during pregnancy. Maternal and fetal tachycardia have occurred with use and pulmonary edema has been reported with maternal use of beta stimulants (Brazy, 1979; Brazy, 1981). Although isoxsuprine has been evaluated for the treatment of premature labor, use for this indication is not currently recommended (ACOG, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F185250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Isoxsuprine HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (100): $84.00",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539883\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Angiclan (ES);",
"     </li>",
"     <li>",
"      Dilator (PE);",
"     </li>",
"     <li>",
"      Dilum (PT);",
"     </li>",
"     <li>",
"      Duvadilan (AE, AR, AU, BE, BH, CY, DE, EG, ES, FR, GR, IE, IL, IN, IQ, IR, JO, KW, LB, LU, LY, NL, OM, PH, QA, SA, SY, VE, YE);",
"     </li>",
"     <li>",
"      Duvadilan Retard (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, NL, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Duvagen (PH);",
"     </li>",
"     <li>",
"      Hystolan (ID);",
"     </li>",
"     <li>",
"      Inibina (BR);",
"     </li>",
"     <li>",
"      Isodilan (PE);",
"     </li>",
"     <li>",
"      Isoprin (TW);",
"     </li>",
"     <li>",
"      Isoxilan (PH);",
"     </li>",
"     <li>",
"      Proterine (ID);",
"     </li>",
"     <li>",
"      Synzedrin (JP);",
"     </li>",
"     <li>",
"      Uterine (AR, PY);",
"     </li>",
"     <li>",
"      Vasoplex (DE);",
"     </li>",
"     <li>",
"      Vasosuprina (IT);",
"     </li>",
"     <li>",
"      Xuprin (AT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F185235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In studies on normal human subjects, isoxsuprine increases muscle blood flow, but skin blood flow is usually unaffected. Rather than increasing muscle blood flow by beta-receptor stimulation, isoxsuprine probably has a direct action on vascular smooth muscle. The generally accepted mechanism of action of isoxsuprine on the uterus is beta-adrenergic stimulation. Isoxsuprine was shown to inhibit prostaglandin synthetase at high serum concentrations, with low concentrations there was an increase in the P-G synthesis.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F185247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid and complete",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: ~1 hour; serum concentrations maintained for at least 3 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      ACOG Practice Bulletin No. 127: &ldquo;Management of Preterm Labor,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2012, 119(6):1308.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/36/10819/abstract-text/22617615/pubmed\" id=\"22617615\" target=\"_blank\">",
"        22617615",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/36/10819/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brazy JE and Pupkin MJ. &ldquo;Effects of Maternal Isoxsuprine Administration on Preterm Infants,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1979, 94(3):444-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/36/10819/abstract-text/423034/pubmed\" id=\"423034\" target=\"_blank\">",
"        423034",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brazy JE, Little V, Grimm J. &ldquo;Isoxsuprine in the Perinatal Period. II. Relationships Between Neonatal Symptoms, Drug Exposure, and Drug Concentration at the Time of Birth,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1981, 98(1):146-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/36/10819/abstract-text/7192732/pubmed\" id=\"7192732\" target=\"_blank\">",
"        7192732",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kaindl F, Samuels SS, Selman D, et al, &ldquo;A New Vasodilating and Antispasmodic Agent: Isoxsuprine Hydrochloride,&rdquo;",
"      <i>",
"       Angiology",
"      </i>",
"      , 1959, 10(4):185-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/36/10819/abstract-text/14404026/pubmed\" id=\"14404026\" target=\"_blank\">",
"        14404026",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8584 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-D1AB04EF24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10819=[""].join("\n");
var outline_f10_36_10819=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185282\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185258\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185259\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160054\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160055\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185244\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185232\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185245\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185286\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185280\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185248\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9958836\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299551\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185239\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13765949\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185250\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539883\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185235\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185247\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8584\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8584|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_36_10820="Ketamine: Patient drug information";
var content_f10_36_10820=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ketamine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     see \"Ketamine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/18/40229?source=see_link\">",
"     see \"Ketamine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F185725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ketalar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F185726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ketalar&reg;;",
"     </li>",
"     <li>",
"      Ketamine Hydrochloride Injection, USP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10011865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700335",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause hallucinations and confusion. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put you to sleep for surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702345",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ketamine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703240",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Aneurysm, chest pain, high blood pressure, raised pressure in the brain, mental illness, overactive thyroid gland, or weak heart.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hallucinations.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698973",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11499 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-C50D28AF5E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10820=[""].join("\n");
var outline_f10_36_10820=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185725\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185726\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011865\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011867\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011866\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011870\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011871\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011873\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011869\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011875\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=related_link\">",
"      Ketamine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/18/40229?source=related_link\">",
"      Ketamine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_36_10821="Tracheal tumors";
var content_f10_36_10821=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tracheal tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10821/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10821/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10821/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10821/contributors\">",
"     Arthur T Skarin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10821/contributors\">",
"     Brian Kavanagh, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10821/contributors\">",
"     Joseph S Friedberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10821/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10821/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/36/10821/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology, pathology, clinical presentation, treatment and prognosis of primary tracheal tumors will be reviewed here.",
"   </p>",
"   <p>",
"    Depending upon histology and location, tracheal tumors may overlap with primary lung cancers or head and neck lesions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=see_link\">",
"       \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=see_link\">",
"       \"Overview of head and neck cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary tracheal tumors are rare. The largest reported series comes from a Surveillance, Epidemiology and End Results (SEER) analysis of 578 cases or primary tracheal carcinoma identified over a 31 year period [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/1\">",
"     1",
"    </a>",
"    ]. In that series, the mean age was 63 years, and 56 percent of patients were male. Similar results were seen in population-based studies from tumor registries in Finland, Denmark, and the Netherlands, which reported an annual incidence of tracheal cancer of approximately 0.1 per 100,000 per year, with tracheal cancers accounting for less than one-half of one percent of all malignant tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. In these series, the mean age at presentation was approximately 60 years and about 70 percent of cases occurred in males.",
"   </p>",
"   <p>",
"    Primary tracheal tumors are exceedingly rare in children. A 1998 review of the literature identified a total of 38 cases over a 30 year period, of which approximately two-thirds were benign [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/5\">",
"     5",
"    </a>",
"    ]. In children, papillomas, hemangiomas, and granular cell tumors are most common tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In tumor-registry analyses [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/1-4\">",
"     1-4",
"    </a>",
"    ], the majority of tracheal tumors in adults are malignant, with about one-half to two-thirds being squamous cell carcinomas (SCCs); adenoid cystic carcinomas (ACCs) were the second most common, accounting for about 10 to 15 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The remaining cases include a variety of other tumor types. Benign tracheal lesions include hemangioma, hamartoma, neurogenic tumors, granular cell tumor, and squamous papillomas [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      SCCs of the trachea are histologically identical to SCCs of the lung. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=see_link\">",
"       \"Pathology of lung malignancies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      ACCs of the tracheobronchial tree are identical to ACCs of the salivary glands. ACCs typically form polypoid lesions in the trachea or main stem bronchi, but they may form infiltrative plaques with longitudinal or circumferential extension and often breach the cartilaginous plate. Perineural invasion and extension along vascular structures is very common and account for the high rate of positive surgical margins, well beyond the gross limits of the tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. ACCs can have multiple recurrences with late metastases (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59006 \" href=\"UTD.htm?2/16/2308\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Mucoepidermoid carcinomas (MECs) are histologically identical to MEC of the salivary gland. MEC is characterized by squamous cells, mucin secreting cells, and intermediate cells. MECs arise from bronchial glands in the central airways and more common in the bronchi than in the trachea [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. They are usually well delineated polypoid tumors. Based upon morphology, MEC are divided into low and high grade types [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/11\">",
"       11",
"      </a>",
"      ]. Low-grade tumors seldom (&lt;5 percent) spread to regional lymph nodes, while high-grade tumors spread to regional nodes frequently and metastasize distantly.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PRESENTATION, DIAGNOSIS, STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common presenting symptoms of tracheal tumors are due to the presence of a mass within the trachea. These include cough, hoarseness, dyspnea, hemoptysis, and wheeze with or without stridor. Many patients are initially misdiagnosed with asthma, especially with more indolent tumors. Hemoptysis is frequent with squamous cell carcinoma.",
"   </p>",
"   <p>",
"    Chest radiographs are rarely diagnostic. CT is the best method of imaging and detecting tracheal or major bronchi lesions (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70319 \" href=\"UTD.htm?29/22/30049\">",
"     image 2",
"    </a>",
"    ). Pulmonary function testing with flow-volume loops may demonstrate flattening of the inspiratory (extrathoracic tumor) or expiratory (intrathoracic tumor) loop or both if there is substantial involvement of the trachea but this finding is not observed with smaller lesions or involvement of just one main stem bronchus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchoscopy is the usual means of obtaining tissue for histologic confirmation of the diagnosis and is useful in assessing the resectability of the tumor (",
"    <a class=\"graphic graphic_picture graphicRef79952 \" href=\"UTD.htm?40/24/41359\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    No staging system has been established by the Union Internationale Centre le Cancer (UICC) or the American Joint Committee on Cancer (AJCC). One staging system that has been used by some investigators is based upon the TNM system and derived from the Surveillance, Epidemiology and End Results (SEER) database [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/14\">",
"     14",
"    </a>",
"    ]. The main limitation of this system is the small number of cases with insufficient information to allow accurate assessment of its ability to predict survival.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary treatment modalities are surgery and radiation therapy. The outcome of treatment is dependent also upon the histology of the tracheal tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical resection is the treatment of choice for malignant tracheal tumors whenever possible. However, surgical resection appears to be underutilized. In a population-based study of 308 cases seen from 1989 to 1992 in the Netherlands, only 12 percent of patients underwent resection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/4\">",
"     4",
"    </a>",
"    ]. A subsequent analysis of a more recent series from the same group found that 12 of 50 cases treated between 2000 and 2005 underwent resection; however, chart review found that an additional 16 of 50 cases were candidates for resection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Much higher rates of resectability have been seen in surgical series. In the series from Massachusetts General Hospital, 191 of 270 patients (71 percent) with squamous cell carcinoma (SCC) or adenoid cystic carcinoma (ACC) were resectable [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/16\">",
"     16",
"    </a>",
"    ]. The 30-day operative mortality rate ranged from 7 to 11 percent in three large reports [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/10,17,18\">",
"     10,17,18",
"    </a>",
"    ] with the study from one large center observing a decreasing operative mortality over the last four decades, to 3 percent in the period from 1992-2001.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative radiation therapy (RT) is frequently utilized for patients with SCC and ACC, but it is not certain how whether this improves survival since there are no controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/10,18,19\">",
"     10,18,19",
"    </a>",
"    ]. RT is frequently given to patients with incomplete resection or positive margins.",
"   </p>",
"   <p>",
"    RT has also been used as the primary treatment for tracheal malignancies. In the Netherlands database series, 156 patients (53 percent) were treated with RT alone [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/4\">",
"     4",
"    </a>",
"    ]. The median survival time was 11 months and the five-year survival rate was 11 percent, which was markedly inferior to the results with surgery with or without radiotherapy. However, this was not a randomized trial and there was obvious selection bias in treatment.",
"   </p>",
"   <p>",
"    Rigid bronchoscopy with laser resection",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stents can be utilized as a bridge to surgery. These approaches can also be employed for palliation in unresectable cases. The benefits are usually temporary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Outcomes from treatment",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2738416\">",
"    <span class=\"h3\">",
"     Effect of stage and histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important factor affecting prognosis is the extent of disease at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/1\">",
"     1",
"    </a>",
"    ]. In the SEER database series of 578 patients, those with localized disease had a significantly better prognosis than those with regional disease or distant metastases (five-year survival rates, 47, 26, and 4 percent, respectively). Histology also had a significant impact on prognosis; patients with squamous cell carcinoma did significantly worse than those with adenoid cystic carcinoma (five-year survival rate 13 versus 74 percent). Even among patients with localized squamous cell carcinoma, the prognosis was worse that with adenoid cystic carcinoma (five-year survival 25 versus 91 percent).",
"   </p>",
"   <p>",
"    The better prognosis for patients with adenoid cystic carcinoma may reflect slower growth of these tumors and a more prolonged natural history, as has been described for patients with adenoid cystic carcinoma arising in salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Squamous cell carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most extensive experience with SCC of the trachea comes from a hospital-based series of 135 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/18\">",
"     18",
"    </a>",
"    ]. In this series, 90 patients (67 percent) underwent resection and 41 of these (46 percent) received postoperative RT. The 5 and 10-year survival rates in patients undergoing resection were 39 and 18 percent, respectively, compared to 7 and 5 percent, respectively, for unresectable patients. A multicenter French surgical series included 83 resected tracheal cancers, most of which were SCCs, and 49 (59 percent) received adjuvant RT [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/17\">",
"     17",
"    </a>",
"    ]. They observed 5 and 10-year survival rates of 47 and 36 percent, respectively.",
"   </p>",
"   <p>",
"    In contrast, the Netherlands population database study reported an overall five-year survival of only 12 percent for all 156 patients with SCC, but the resection rate was only 12 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Adenoid cystic carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been several surgical series that included significant numbers of patients with ACC [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/10,16,17,24\">",
"     10,16,17,24",
"    </a>",
"    ]. The results in ACC are illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A hospital-based series from the United States reported on 101 patients in whom ACC was resected; 70 percent received postoperative radiation. The 5 and 10-year survival rates were 52 and 29 percent, respectively. In 34 patients with unresectable ACC, the five-year survival was 33 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A French series reported 5 and 10-year survival rates of 73 and 57 percent for all patients undergoing surgical resection, with 26 of 60 (43 percent) receiving adjuvant RT [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a Canadian series, 32 of 38 patients with ACC of the upper airway were resected and 26 treated with adjuvant radiotherapy [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/10\">",
"       10",
"      </a>",
"      ]. The five-year survival rate for resected patients was 79 percent with 51 percent survival at 10 years.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study comparing outcomes in 270 patients with SCC and ACC (135 each), multivariate analysis of resected patients observed that ACC was associated with a significantly better prognosis than SCC. Other factors associated with an improved outcome included complete resection and negative resection margins [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Mucoepidermoid carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experience in patients with mucoepidermoid carcinoma (MEC) is more limited.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series of 18 MEC lung tumors, 15 were low grade tumors and three were high grade [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/12\">",
"       12",
"      </a>",
"      ]. All 12 patients with low-grade tumors that were completely resected were alive at last follow-up (mean 4.7 years and range of 1 to 27 years). In contrast, all three high-grade tumors were fatal within 16 months [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another series of 18 patients with MEC from Mayo Clinic included eight (44 percent) in which the tumor originated in the trachea and mainstem bronchi while the rest occurred more distally [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/13\">",
"       13",
"      </a>",
"      ]. Surgery was possible in 95 percent of cases (79 percent lobectomy or sleeve resection; 16 percent tracheal resection). Only one case received adjuvant radiation treatment. Survival at both 5 years and 10 years was 87 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10821/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary tracheal tumors are rare and in adults most are malignant. Histologically, the majority of these tumors are squamous cell carcinomas; adenoid cystic carcinomas and mucoepidermoid carcinomas comprise most of the remaining malignant tumors. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with primary malignant tumors of the trachea, we recommend complete surgical resection when possible (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). For patients with positive surgical margins or an incomplete resection, we suggest postoperative radiation therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/1\">",
"      Urdaneta AI, Yu JB, Wilson LD. Population based cancer registry analysis of primary tracheal carcinoma. Am J Clin Oncol 2011; 34:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/2\">",
"      Manninen MP, Antila PJ, Pukander JS, Karma PH. Occurrence of tracheal carcinoma in Finland. Acta Otolaryngol 1991; 111:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/3\">",
"      Licht PB, Friis S, Pettersson G. Tracheal cancer in Denmark: a nationwide study. Eur J Cardiothorac Surg 2001; 19:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/4\">",
"      Honings J, van Dijck JA, Verhagen AF, et al. Incidence and treatment of tracheal cancer: a nationwide study in the Netherlands. Ann Surg Oncol 2007; 14:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/5\">",
"      Desai DP, Holinger LD, Gonzalez-Crussi F. Tracheal neoplasms in children. Ann Otol Rhinol Laryngol 1998; 107:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/6\">",
"      GILBERT JG, MAZZARELLA LA, FEIT LJ. Primary tracheal tumors in the infant and adult. AMA Arch Otolaryngol 1953; 58:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/7\">",
"      Macchiarini P. Primary tracheal tumours. Lancet Oncol 2006; 7:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/8\">",
"      Ahn Y, Chang H, Lim YS, et al. Primary tracheal tumors: review of 37 cases. J Thorac Oncol 2009; 4:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/9\">",
"      Gaissert HA, Grillo HC, Shadmehr MB, et al. Uncommon primary tracheal tumors. Ann Thorac Surg 2006; 82:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/10\">",
"      Maziak DE, Todd TR, Keshavjee SH, et al. Adenoid cystic carcinoma of the airway: thirty-two-year experience. J Thorac Cardiovasc Surg 1996; 112:1522.",
"     </a>",
"    </li>",
"    <li>",
"     Travis WD, Brambilla E, M&uuml;ller-Hermelink HK, Harris CC. of the Lung, Pleura, Thymoma, and Heart. In: World Health Organization Classification of Tumors: Pathology and Genetics, IARC Presee, Lyon, France 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/12\">",
"      Heitmiller RF, Mathisen DJ, Ferry JA, et al. Mucoepidermoid lung tumors. Ann Thorac Surg 1989; 47:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/13\">",
"      Molina JR, Aubry MC, Lewis JE, et al. Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Cancer 2007; 110:2253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/14\">",
"      Bhattacharyya N. Contemporary staging and prognosis for primary tracheal malignancies: a population-based analysis. Otolaryngol Head Neck Surg 2004; 131:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/15\">",
"      Honings J, Gaissert HA, Verhagen AF, et al. Undertreatment of tracheal carcinoma: multidisciplinary audit of epidemiologic data. Ann Surg Oncol 2009; 16:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/16\">",
"      Grillo HC, Mathisen DJ. Primary tracheal tumors: treatment and results. Ann Thorac Surg 1990; 49:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/17\">",
"      Regnard JF, Fourquier P, Levasseur P. Results and prognostic factors in resections of primary tracheal tumors: a multicenter retrospective study. The French Society of Cardiovascular Surgery. J Thorac Cardiovasc Surg 1996; 111:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/18\">",
"      Gaissert HA, Grillo HC, Shadmehr MB, et al. Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina. Ann Thorac Surg 2004; 78:1889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/19\">",
"      Xie L, Fan M, Sheets NC, et al. The use of radiation therapy appears to improve outcome in patients with malignant primary tracheal tumors: a SEER-based analysis. Int J Radiat Oncol Biol Phys 2012; 84:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/20\">",
"      Cavaliere S, Venuta F, Foccoli P, et al. Endoscopic treatment of malignant airway obstructions in 2,008 patients. Chest 1996; 110:1536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/21\">",
"      Colt HG, Harrell JH. Therapeutic rigid bronchoscopy allows level of care changes in patients with acute respiratory failure from central airways obstruction. Chest 1997; 112:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/22\">",
"      Jeon K, Kim H, Yu CM, et al. Rigid bronchoscopic intervention in patients with respiratory failure caused by malignant central airway obstruction. J Thorac Oncol 2006; 1:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/23\">",
"      Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 2011; 34:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10821/abstract/24\">",
"      Webb BD, Walsh GL, Roberts DB, Sturgis EM. Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience. J Am Coll Surg 2006; 202:237.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4622 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-6BDFF69EB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10821=[""].join("\n");
var outline_f10_36_10821=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PRESENTATION, DIAGNOSIS, STAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Outcomes from treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2738416\">",
"      - Effect of stage and histology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Adenoid cystic carcinoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Mucoepidermoid carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/4622\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4622|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/16/2308\" title=\"diagnostic image 1\">",
"      ACC prev resect pulm mets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/22/30049\" title=\"diagnostic image 2\">",
"      Primary tracheal tumor CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/4622|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/24/41359\" title=\"picture 1\">",
"      Primary tracheal tum ENDO",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/44/30407?source=related_link\">",
"      Overview of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/57/16282?source=related_link\">",
"      Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22201?source=related_link\">",
"      Pathology of lung malignancies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_36_10822="Lumbosacral dermatomes";
var content_f10_36_10822=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F50419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F50419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Lumbosacral dermatomes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 506px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the lumbosacral dermatomes. Patients with sciatica may have pain, paresthesias, and diminished sensation in the dermatome of the nerve root that is involved.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10822=[""].join("\n");
var outline_f10_36_10822=null;
var title_f10_36_10823="Rationale for and mechanisms of benefit of cardiac resynchronization therapy";
var content_f10_36_10823=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Rationale for and mechanisms of benefit of cardiac resynchronization therapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10823/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10823/contributors\">",
"     Leslie A Saxon, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10823/contributors\">",
"     Teresa DeMarco, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10823/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10823/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10823/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10823/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/36/10823/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical therapies, such as angiotensin converting enzyme inhibitors, beta blockers, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    , have led to marked improvements in both symptom control and overall survival in patients with heart failure (HF). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Implanted devices, such as cardioverter-defibrillators (ICDs) and pacemakers, can also be beneficial. In particular, ICDs are now recommended for primary prevention of sudden cardiac death in selected patients with ischemic and nonischemic cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19322?source=see_link&amp;anchor=H28#H28\">",
"     \"Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy\", section on 'Primary prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, some HF patients benefit from simultaneous pacing of both ventricles (biventricular or BiV pacing) or of one ventricle in patients with bundle branch block. This approach is referred to as cardiac resynchronization therapy (CRT) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. CRT can be achieved with a device designed only for pacing or can be incorporated into a combination device with an ICD (",
"    <a class=\"graphic graphic_figure graphicRef79450 \" href=\"UTD.htm?15/35/15925\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    CRT is now recommended across a spectrum of patients with heart failure due to systolic dysfunction in association with QRS delay [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Initial studies of CRT therapy resulted in United States Food and Drug Administration (FDA) approval for patients with advanced HF (usually NYHA class III or IV), severe systolic dysfunction (eg, left ventricular ejection fraction &le;35 percent) and intraventricular conduction delay (eg, QRS &gt;120 msec). More recently, based on the positive results of the MADIT-CRT trial which evaluated CRT in the setting of Class I-II heart failure with QRS delay, the FDA has approved CRT to this class of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link&amp;anchor=H3#H3\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\", section on 'Clinical trials'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rationale for CRT is that ventricular dyssynchrony can further impair the pump function of a failing ventricle. Resynchronization may improve pump performance and reverse the deleterious process of ventricular remodeling.",
"   </p>",
"   <p>",
"    The rationale for and mechanisms of benefit from cardiac resynchronization therapy (CRT) in patients with HF will be reviewed here. The role of CRT in the management of patients with HF and the role of CRT in patients with atrial fibrillation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/61/983?source=see_link\">",
"     \"Cardiac resynchronization therapy in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RATIONALE FOR CRT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rationale for CRT is based upon the observation that the presence of a bundle branch block or other intraventricular conduction delay can worsen HF due to systolic dysfunction by causing ventricular dyssynchrony, thereby inducing regional loading disparities and reducing the efficiency of contraction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ]. Consistent with the idea that ventricular dyssynchrony exacerbates left ventricular dysfunction is the observation that a variety of hemodynamic benefits follow the correction of dyssynchrony with CRT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Adverse effects of conduction abnormalities and ventricular pacing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial support for the hypothesis that dyssynchrony exacerbates HF came from several observational studies in which an intraventricular conduction delay (IVCD) or left bundle branch block (LBBB) was associated with worsening of symptom class status and poorer overall outcome compared to matched patients with normal intraventricular conduction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the symptomatic impact of dyssynchrony is most significant in patients with underlying left ventricular (LV) dysfunction and HF, the adverse effect of LBBB or IVCD on LV function is not limited to patients with HF [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In one report, for example, isolated LBBB was associated with dyssynchronous contraction and lower left ventricular ejection fraction (LVEF) than found among normals (54 versus 62 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar adverse hemodynamic effects occur with right ventricular pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Standard ventricular pacing causes the right ventricle to contract before the left ventricle (interventricular dyssynchrony), and simulates the effect of left bundle branch block, causing the septum to contract before the lateral wall (intraventricular dyssynchrony). Based upon these and other observations, which are discussed in detail elsewhere, standard (univentricular) dual-chamber pacing is not generally recommended for the treatment of HF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31510?source=see_link\">",
"     \"Overview of cardiac pacing in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISMS OF BENEFIT",
"    </span>",
"    &nbsp;&mdash;&nbsp;As described separately, a number of randomized controlled trials have shown improved outcomes with CRT in appropriately selected patients with systolic HF who have an IVCD or LBBB. Potential mechanisms of benefit include improved contractile function and reverse ventricular remodeling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The molecular basis for these mechanical changes has not been established. Preliminary data from an experimental model suggests that CRT reduces regional and global molecular remodeling, generating more homogeneous activation of stress kinases and reducing apoptosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Improved contractile function",
"    </span>",
"    &nbsp;&mdash;&nbsp;CRT improves LV contractile function in patients with HF associated with an IVCD or LBBB [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. This improvement is associated with greater coordination of global contraction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/21\">",
"     21",
"    </a>",
"    ]. The magnitude of this effect can be illustrated by the following observations from two randomized trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the CARE-HF trial in which the median LVEF was 25 percent at baseline, the LVEF in the CRT compared to no CRT group increased by 3.7 percent at three months and 6.9 percent at 18 months [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/19\">",
"       19",
"      </a>",
"      ]. The increase in contractile function was associated with a rise in systolic pressure of about 6 mmHg compared to no CRT (median baseline 110 mmHg) and a reduction in plasma N-terminal-pro-brain natriuretic peptide (BNP) of 225",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      at three months and 1122",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      at 18 months (median baseline 1800 to 1900",
"      <span class=\"nowrap\">",
"       pg/mL).",
"      </span>",
"     </li>",
"     <li>",
"      A similar improvement was demonstrated in an analysis from the MIRACLE trial in which the LVEF in 323 patients was measured at baseline and at three and six months of therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/20\">",
"       20",
"      </a>",
"      ]. At six months, there was a significantly greater increase in LVEF with CRT than without (3.6 versus 0.4 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The improvements in global measures of LV function are accompanied by additional benefits:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Myocardial efficiency is increased. With CRT, increased contractility is associated with no change or a modest reduction in myocardial energy demands and myocardial oxygen consumption [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/22-24\">",
"       22-24",
"      </a>",
"      ]. This finding is in contrast to the effects of inotropic therapy, which increases myocardial energy demand.",
"     </li>",
"     <li>",
"      CRT restores the normal increase in contractility associated with higher heart rates, a phenomenon that is blunted or reversed in many patients with advanced heart failure [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Reverse ventricular remodeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;BiV pacing is associated with reverse ventricular remodeling in patients with HF [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/3,4,19,20,27-32\">",
"     3,4,19,20,27-32",
"    </a>",
"    ]. In the CARE-HF and MIRACLE trials BiV pacing produced significant reductions in LV end-systolic and end-diastolic dimensions, mitral regurgitant jet area, and, in MIRACLE, LV mass, all of which are signs of reverse remodeling [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/19,20,31,33\">",
"     19,20,31,33",
"    </a>",
"    ]. In a follow-up study from the MIRACLE trial, these favorable changes persisted at 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9799?source=see_link&amp;anchor=H10#H10\">",
"     \"Functional mitral regurgitation\", section on 'Cardiac resynchronization therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reverse remodeling was also observed in the CONTAK CD, PATH-CHF, and VIGOR CHF trials [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/27,34,35\">",
"     27,34,35",
"    </a>",
"    ]. Tissue Doppler echocardiography suggests that the main mechanism of benefit is improved mechanical synchrony [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/28,35\">",
"     28,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/52/842?source=see_link\">",
"     \"Cardiac remodeling: Clinical assessment and therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relationship between reverse remodeling and long-term clinical outcomes was evaluated in a study of 141 patients with advanced HF on standard medical therapy who were treated with CRT [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/36\">",
"     36",
"    </a>",
"    ]. Serial echocardiograms, including tissue Doppler imaging, were performed at baseline and three and six months after BiV pacemaker implantation. Responders with reverse remodeling were defined as those patients with &ge;10 percent reduction in LV end-systolic volume (LVESV). At a mean follow-up of almost two years, the following findings were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      87 patients (62 percent) were defined as responders with evidence of reverse remodeling.",
"     </li>",
"     <li>",
"      Responders had lower all-cause mortality compared to nonresponders (7 versus 31 percent), and lower cardiovascular mortality (2.3 versus 24 percent).",
"     </li>",
"     <li>",
"      Responders had fewer heart failure events compared to nonresponders (12 versus 33 percent).",
"     </li>",
"     <li>",
"      In multivariate analysis, among a number of clinical and echocardiographic parameters, only a reduction in LVESV was an independent predictor of all-cause or cardiovascular mortality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings support the hypothesis that reverse remodeling is an important component of the benefit from CRT. However, although both reverse remodeling and symptomatic improvement occur with CRT, it is not clear that these two phenomena correlate directly with one another or if remodeling is necessary for patients to achieve symptomatic benefit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further hemodynamic and clinical benefits during acute or chronic BiV or LV pacing include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An increase in cardiac index and a reduction in pulmonary capillary wedge pressure, when compared to normal sinus rhythm or RV pacing [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/37-41\">",
"       37-41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The ability to tolerate more aggressive medical therapy and neurohormonal blockade, particularly with improved tolerance of beta blockers [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Improved diastolic function among responders to CRT [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Improvement in heart rate variability (HRV) [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/44\">",
"       44",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/39/35449?source=see_link&amp;anchor=H7#H7\">",
"       \"Heart rate variability: Uses other than after myocardial infarction\", section on 'RR variability and outcome in heart failure'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although some small studies suggested that CRT might reduce the frequency of ventricular [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/45\">",
"     45",
"    </a>",
"    ] or atrial arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/46\">",
"     46",
"    </a>",
"    ], larger trials have not demonstrated a significant reduction in either ventricular [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/34,47,48\">",
"     34,47,48",
"    </a>",
"    ] or atrial [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10823/abstract/49\">",
"     49",
"    </a>",
"    ] arrhythmias. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/61/983?source=see_link\">",
"     \"Cardiac resynchronization therapy in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/34/37410?source=see_link\">",
"       \"Patient information: Cardiac resynchronization therapy (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rationale for cardiac resynchronization therapy (CRT) is based upon the observation that the presence of a bundle branch block or other intraventricular conduction delay can worsen heart failure due to systolic dysfunction by causing ventricular dyssynchrony.",
"     </li>",
"     <li>",
"      Consistent with the concept that left ventricular dyssynchrony exacerbates ventricular dysfunction is the observation that a variety of hemodynamic benefits as well as improved clinical outcomes follow the correction of dyssynchrony with CRT.",
"     </li>",
"     <li>",
"      Mechanisms of benefit from CRT include improvement in left ventricular systolic function as well as reverse ventricular remodeling manifest as reductions in left ventricular chamber size and measures of mitral regurgitation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17794843\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and editors would like to thank Dr. Kumar for his contributions as an author to previous versions of this topic.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/1\">",
"      Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002; 39:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/2\">",
"      Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation 2003; 108:2596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/3\">",
"      Auricchio A, Abraham WT. Cardiac resynchronization therapy: current state of the art: cost versus benefit. Circulation 2004; 109:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/4\">",
"      Leclercq C, Hare JM. Ventricular resynchronization: current state of the art. Circulation 2004; 109:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/5\">",
"      Jarcho JA. Resynchronizing ventricular contraction in heart failure. N Engl J Med 2005; 352:1594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/6\">",
"      Burkhardt JD, Wilkoff BL. Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure. Circulation 2007; 115:2208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/7\">",
"      Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/8\">",
"      Jessup M. MADIT-CRT--breathtaking or time to catch our breath? N Engl J Med 2009; 361:1394.",
"     </a>",
"    </li>",
"    <li>",
"     US Food and Drug Administration. FDA approves devices for heart failure patients. file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226123.htm (Accessed on October 21, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/10\">",
"      Duncan AM, Francis DP, Gibson DG, Henein MY. Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle-branch block and coronary artery disease. J Am Coll Cardiol 2004; 43:1524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/11\">",
"      Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999; 70:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/12\">",
"      Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 2002; 143:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/13\">",
"      Grines CL, Bashore TM, Boudoulas H, et al. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation 1989; 79:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/14\">",
"      Murkofsky RL, Dangas G, Diamond JA, et al. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see comment]. J Am Coll Cardiol 1998; 32:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/15\">",
"      Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/16\">",
"      Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107:2932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/17\">",
"      Sweeney MO, Prinzen FW. A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 2006; 47:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/18\">",
"      Chakir K, Daya SK, Tunin RS, et al. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 2008; 117:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/19\">",
"      Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/20\">",
"      St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107:1985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/21\">",
"      Kerwin WF, Botvinick EH, O'Connell JW, et al. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000; 35:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/22\">",
"      Ukkonen H, Beanlands RS, Burwash IG, et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003; 107:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/23\">",
"      Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102:3053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/24\">",
"      Sundell J, Engblom E, Koistinen J, et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 2004; 43:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/25\">",
"      Vollmann D, L&uuml;thje L, Schott P, et al. Biventricular pacing improves the blunted force-frequency relation present during univentricular pacing in patients with heart failure and conduction delay. Circulation 2006; 113:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/26\">",
"      Kass DA. Cardiac resynchronization therapy and cardiac reserve: how you climb a staircase may alter its steepness. Circulation 2006; 113:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/27\">",
"      Saxon LA, De Marco T, Schafer J, et al. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002; 105:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/28\">",
"      Yu CM, Chau E, Sanderson JE, et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002; 105:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/29\">",
"      Sutton MG, Plappert T, Hilpisch KE, et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 2006; 113:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/30\">",
"      Donal E, Leclercq C, Linde C, Daubert JC. Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J 2006; 27:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/31\">",
"      Zhang Q, Fung JW, Auricchio A, et al. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure. Eur Heart J 2006; 27:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/32\">",
"      Bleeker GB, Mollema SA, Holman ER, et al. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline. Circulation 2007; 116:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/33\">",
"      Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003; 41:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/34\">",
"      Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42:1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/35\">",
"      Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001; 38:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/36\">",
"      Yu CM, Bleeker GB, Fung JW, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005; 112:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/37\">",
"      Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998; 32:1825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/38\">",
"      Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994; 17:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/39\">",
"      Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997; 96:3273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/40\">",
"      Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999; 99:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/41\">",
"      Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999; 99:2993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/42\">",
"      Aranda JM Jr, Woo GW, Conti JB, et al. Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. Am J Cardiol 2005; 95:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/43\">",
"      Waggoner AD, Faddis MN, Gleva MJ, et al. Improvements in left ventricular diastolic function after cardiac resynchronization therapy are coupled to response in systolic performance. J Am Coll Cardiol 2005; 46:2244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/44\">",
"      Fantoni C, Raffa S, Regoli F, et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 2005; 46:1875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/45\">",
"      Ermis C, Seutter R, Zhu AX, et al. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005; 46:2258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/46\">",
"      Yannopoulos D, Lurie KG, Sakaguchi S, et al. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure. J Am Coll Cardiol 2007; 50:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/47\">",
"      Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003; 289:2685.",
"     </a>",
"    </li>",
"    <li>",
"     Gold MR. Effect of cardiac resynchronization therapy on incidence of spontaneous ventricular arrhythmias in mild heart failure: Results from the REVERSE trial. Heart Rhythm Society 2008 Scientific Sessions.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10823/abstract/49\">",
"      Hoppe UC, Casares JM, Eiskjaer H, et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006; 114:18.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3484 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-75FCE2A03D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10823=[""].join("\n");
var outline_f10_36_10823=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RATIONALE FOR CRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Adverse effects of conduction abnormalities and ventricular pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISMS OF BENEFIT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Improved contractile function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Reverse ventricular remodeling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17794843\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/3484\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3484|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/35/15925\" title=\"figure 1\">",
"      Cardiac resynchronization leads",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/52/842?source=related_link\">",
"      Cardiac remodeling: Clinical assessment and therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/61/983?source=related_link\">",
"      Cardiac resynchronization therapy in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=related_link\">",
"      Cardiac resynchronization therapy in heart failure: Indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9799?source=related_link\">",
"      Functional mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/39/35449?source=related_link\">",
"      Heart rate variability: Uses other than after myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31510?source=related_link\">",
"      Overview of cardiac pacing in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/34/37410?source=related_link\">",
"      Patient information: Cardiac resynchronization therapy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/55/19322?source=related_link\">",
"      Secondary and primary prevention of sudden cardiac death in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_36_10824="Brain MRI 1-year-old girl Canavan disease";
var content_f10_36_10824=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F83743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F83743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Brain MRI, 1-year-old girl with Canavan disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 583px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T2-weighted (A, B) and T1-weighted (C, D) MRI of the brain showing severe and diffuse T2 hyperintense and T1 hypointense signal changes in the white matter suggesting Canavan disease. Significant involvement of U fibers is present. Multiple round or oval cystic changes within the white matter give a honeycomb appearance. The radial arrangement of these cystic spaces suggests dilatation of Virchow-Robin spaces due to spongiform degeneration of the white matter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pradhan S, Goyal G. Teaching NeuroImages: honeycomb appearance of the brain in a patient with Canavan disease. Neurology 2011; 76:e68. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10824=[""].join("\n");
var outline_f10_36_10824=null;
var title_f10_36_10825="Urinary system anatomy";
var content_f10_36_10825=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F83477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F83477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 514px\">",
"   <div class=\"ttl\">",
"    Urinary system anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 494px; height: 694px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Company. Copyright &copy; 2012 Wolters Kluwer Health.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10825=[""].join("\n");
var outline_f10_36_10825=null;
var title_f10_36_10826="Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis";
var content_f10_36_10826=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10826/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10826/contributors\">",
"     Sergio D Rosenzweig, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10826/contributors\">",
"     Steven M Holland, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10826/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10826/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/36/10826/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/36/10826/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/36/10826/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic granulomatous disease (CGD) is a genetically heterogeneous condition characterized by recurrent life-threatening bacterial and fungal infections and granuloma formation. CGD is caused by defects in the phagocyte NADPH oxidase (phox). These genetic defects result in the inability of phagocytes (neutrophils, monocytes, and macrophages) to destroy certain microbes. The diagnosis is made by neutrophil function testing and then the exact defect is determined by genotyping.",
"   </p>",
"   <p>",
"    Infections are generally caused by catalase-positive microorganisms (most bacterial and all fungal pathogens are catalase-positive). The frequent sites of infection are lung, skin, lymph nodes, and liver. The formation of granulomata is especially problematic in the gastrointestinal and genitourinary tracts. Other inflammatory manifestations are seen as well.",
"   </p>",
"   <p>",
"    This topic will review the pathogenesis, clinical manifestations, and diagnosis of CGD. The treatment and prognosis of CGD, as well as an overview of primary disorders of phagocyte function, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11465?source=see_link\">",
"     \"Chronic granulomatous disease: Treatment and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link\">",
"     \"Primary disorders of phagocytic function: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phagocytes utilize NADPH oxidase to generate reactive species of oxygen. CGD arises from mutations that result in the loss or functional inactivation of one of the subunits of the NADPH oxidase complex.",
"   </p>",
"   <p>",
"    The fully assembled NADPH oxidase is a five-protein complex. In the basal state, it exists as two components [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The membrane-bound heterodimer, called cytochrome b-245 or cytochrome b588, that is composed of gp91phox and p22phox and is embedded in the walls of secondary granules",
"     </li>",
"     <li>",
"      Proteins in the cytosol (p47phox, p67phox, and p40phox)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All of these proteins are necessary for the proper generation of superoxide. Activation and assembly of the functional oxidase also requires the participation of Rac2, a small GTP-binding protein, and Rap1, a small GTPase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Activation of NADPH oxidase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cytosolic components p47phox and p67phox are phosphorylated and bind tightly together after cellular activation is initiated by phagocytosis of microbes. In association with p40phox and Rac2, these proteins combine with the cytochrome complex (gp91phox and p22phox) to form the intact NADPH oxidase. An electron is then taken from NADPH and donated to molecular oxygen, leading to the formation of superoxide. This is converted to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    by superoxide dismutase. In the final step, hydrogen peroxide is converted to hypochlorous acid, or bleach, in the presence of myeloperoxidase and chlorine in the neutrophil phagosome (",
"    <a class=\"graphic graphic_figure graphicRef72548 \" href=\"UTD.htm?39/13/40151\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Respiratory burst",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rapid consumption of oxygen and production of superoxide and its metabolites is referred to as the respiratory burst. Phagocyte production of reactive oxygen species leads to the activation of granule proteases, including elastase and cathepsin G. These proteases are responsible for the destruction of ingested (phagocytosed) microorganisms. Thus, superoxide acts as an intracellular activating molecule and not as a direct microbicidal molecule, as was previously thought [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Genetic defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mutations in all five genes (gp91phox, p47phox, p22phox, p67phox, and p40phox) that make up the NADPH oxidase complex account for all of the known cases of CGD. There are one X-linked and four autosomal recessive forms of CGD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The gene for",
"      <strong>",
"       gp91phox",
"      </strong>",
"      is encoded by CYBB, located at Xp21.1. Defects in this gene cause X-linked CGD (MIM 306400), which account for about 65 to 70 percent of cases.",
"     </li>",
"     <li>",
"      The second membrane component,",
"      <strong>",
"       p22phox",
"      </strong>",
"      , is encoded by CYBA, located at chromosome 16q24. Defects in this gene cause an autosomal recessive CGD (MIM 233690), which account for less than 5 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cytosolic factor",
"      <strong>",
"       p47phox",
"      </strong>",
"      is encoded by NCF1, located at 7q11.23 (MIM 233700). Defects in this gene account for about 25 percent of cases.",
"     </li>",
"     <li>",
"      The cytosolic factor,",
"      <strong>",
"       p67phox",
"      </strong>",
"      , is encoded by NCF2, located at chromosome 1q25 (MIM 233710). Defects in NCF2 account for less than 5 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/4-8\">",
"       4-8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cytosolic factor, p40phox, is encoded by NCF4, located at 22a13.1 (MIM 601488). Defects in NCF4 have been described causing severe inflammatory bowel disease in a single child with mildly impaired respiratory burst activity [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neutrophil immunodeficiency syndrome, a syndrome similar to CGD, is caused by a mutation in the RAC2 gene. Two patients with dominant negative mutations in RAC2 have been identified, the first presented with severe bacterial infections and poor wound healing. This patient's neutrophils exhibited decreased superoxide production, as well as impaired chemotaxis and adhesion [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/10\">",
"     10",
"    </a>",
"    ]. The second case was identified by newborn screening and transplanted before disease manifestations were seen [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The large majority of the identified mutations in the phagocyte oxidase (phox) proteins result in complete or nearly complete absence of the protein. A normal amount of a nonfunctioning or hypofunctioning protein results from the other mutations. The superscripts +, -, and 0 are used to indicate normal, decreased, or absent protein levels, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A macrophage-specific defect in gp91phox appears to predispose more to mycobacterial disease than the other infections typically seen in CGD [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/12\">",
"     12",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=see_link\">",
"     \"Mendelian susceptibility to mycobacterial diseases (MSMD)\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Innate immune receptors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CGD, compared to the general population of patients with bacterial pneumonia, express lower levels of several neutrophil receptors, including Toll-like receptors (TLR5 and TLR9), complement receptors (CD11b, CD18, and CD35), and a chemokine receptor (CXCR1). In contrast, patients with pneumonia who do not have CGD generally have higher than normal expression levels of these proteins. Decreased expression results in impaired neutrophil activation (TLR5), phagocytosis",
"    <span class=\"nowrap\">",
"     (CD11b/CD18),",
"    </span>",
"    and chemotaxis (CXCR1). Levels of expression of TLR5 and CD18 may correlate with CGD disease severity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Enhanced inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several different mechanisms may be involved in the enhanced inflammation seen in patients with CGD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Tryptophan catabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;A hyperinflammatory phenotype is associated with dysfunction of a superoxide-dependent step in tryptophan catabolism along the kynurenine pathway in a mouse model of CGD [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/14\">",
"     14",
"    </a>",
"    ]. However, this abnormality is not present in human CGD patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Inflammatory mediators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defective production of reactive oxygen species leads to increased expression of NF-kappaB-regulated inflammatory genes [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/16\">",
"     16",
"    </a>",
"    ]. Higher levels of inflammatory mediators are expressed in monocytes from patients with X-linked CGD without acute infection compared with controls. A similar increase in transcription of anti-inflammatory mediators is not seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Efferocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Efferocytosis is the process by which apoptotic inflammatory cells are recognized and removed by phagocytes. In a mouse model of CGD, efferocytosis by macrophages is suppressed [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of CGD in the United States is approximately 1:200,000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/4\">",
"     4",
"    </a>",
"    ]. The disease primarily affects males, as most mutations are X-linked. Rates are almost identical across ethnic and racial groups, with about one-third of the X-linked mutations occurring de novo. However, the autosomal recessive forms of CGD are more common and overall incidence rates may be higher in cultures in which consanguineous marriage is common [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CGD may present at any time from infancy to late adulthood, but the majority of patients are diagnosed as toddlers and children before the age of five. In several series, the median age at diagnosis was 2.5 to 3 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. More recently, a growing number of patients are diagnosed in later childhood or adulthood. This is due in part to recognition of milder cases of autosomal recessive CGD, as well as delayed diagnosis in some patients. Diagnosis may be delayed because of potent antimicrobials that inadvertently treat many CGD-associated infections, postponing diagnosis until more severe infections indicate CGD as the underlying cause. X-linked CGD tends to have an earlier onset and be more severe than p47phox deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CGD may present with growth failure, abnormal wound healing, diarrhea, or infected dermatitis. They may have hepatomegaly, splenomegaly, or lymphadenitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/23\">",
"     23",
"    </a>",
"    ] on physical examination. A history of recurrent or unusually severe infections, particularly those caused by pathogens commonly associated with CGD, should prompt testing for this disorder. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Infections'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     X-linked carriers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The X-linked carrier state for gp91phox is not entirely silent. In affected women, lyonization (ie, the inactivation of one or the other X chromosome in every cell) leads to two populations of phagocytes: one with normal respiratory burst function, the other with impaired respiratory burst activity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/24\">",
"     24",
"    </a>",
"    ]. Therefore, X-linked CGD carriers display a characteristic mosaic pattern on respiratory burst testing of individual peripheral blood cells microscopically or by flow cytometry.",
"   </p>",
"   <p>",
"    As few as 10 percent of cells having normal respiratory burst activity is sufficient to prevent most severe bacterial and fungal infections. Thus, most female carriers of X-linked gp91phox CGD mutations are not compromised in their ability to handle infectious challenges. However, carriers with less than 10 percent of normal oxidase activity due to skewed X-chromosome lyonization may present with the phenotype of mild to severe CGD [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. Females may have other manifestations of heterozygous carriage of X-linked CGD mutations, including discoid lupus erythematosus, aphthous ulcers, and photosensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CGD typically experience recurrent infections caused by bacterial and fungal pathogens. However, CGD patients may exhibit few clinical signs and symptoms, despite the presence of significant infection. Response to viral infections is normal in patients with CGD.",
"   </p>",
"   <p>",
"    Bacterial infections in CGD tend to be symptomatic and are associated with fever and mildly elevated leukocyte counts [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/31\">",
"     31",
"    </a>",
"    ]. In contrast, fungal infections are associated with less fever and lower leukocytosis and are therefore more difficult to diagnose. Fungal infections are often detected either at asymptomatic stages on routine screening for infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/32\">",
"     32",
"    </a>",
"    ] or at an advanced stage. As an example, patients with fungal osteomyelitis may not be diagnosed until later stages of disease, when they have multiorgan involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Sites of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common sites of infection are lung, skin, lymph nodes, and liver [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The types of infections most often seen (in descending order of frequency) include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pneumonia",
"     </li>",
"     <li>",
"      Abscesses (skin, tissue, organs)",
"     </li>",
"     <li>",
"      Suppurative adenitis",
"     </li>",
"     <li>",
"      Osteomyelitis",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Bacteremia/fungemia",
"      </span>",
"     </li>",
"     <li>",
"      Superficial skin infections",
"      <span class=\"nowrap\">",
"       (cellulitis/impetigo)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pneumonia is the most common pulmonary infection, but patients may also have lung abscesses, empyema, and hilar lymphadenopathy. In contrast to what occurs in neutropenic patients, fungal pneumonias do not generally cavitate in CGD, whereas Nocardia infections do.",
"   </p>",
"   <p>",
"    The most common sites for abscesses are",
"    <span class=\"nowrap\">",
"     perianal/perirectal",
"    </span>",
"    and the liver. Gingivitis, stomatitis, gastroenteritis, and otitis are also common [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/1,4,19-22\">",
"     1,4,19-22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Organisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, the organisms that infect patients with CGD are catalase-producing and include Staphylococcus aureus and Aspergillus species. Catalase is an enzyme that inactivates the",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    normally produced by some bacteria and fungi during growth. Although most microorganisms produce hydrogen peroxide, some do not. It was thought that host phagocytes could use the hydrogen peroxide produced by catalase-negative microbes to generate reactive oxidants. However, the majority of pathogens are catalase-positive, and only a few cause infections in CGD, suggesting that catalase production alone is insufficient for pathogenicity. Furthermore, targeted deletion of the catalase gene in Aspergillus nidulans and Staphylococcus aureus did not affect virulence in animal models of CGD, indicating that microbial catalase is not a significant virulence factor for CGD infections.",
"   </p>",
"   <p>",
"    The overwhelming majority of infections in North America are due to five organisms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Staphylococcus aureus",
"     </li>",
"     <li>",
"      Burkholderia (Pseudomonas) cepacia",
"     </li>",
"     <li>",
"      Serratia marcescens",
"     </li>",
"     <li>",
"      Nocardia",
"     </li>",
"     <li>",
"      Aspergillus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Outside of North America, Salmonella and BCG are frequent infections and should suggest the diagnosis. Other organisms isolated less frequently include Streptococcus species, Neisseria meningitidis, Acinetobacter junii, Candida species, Klebsiella pneumoniae, Mycobacterium tuberculosis, nontuberculous mycobacteria, Proteus species, and Leishmania species [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/19,21,22\">",
"     19,21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bacterial infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of bacterial infections in CGD has decreased since",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    prophylaxis became routine in the 1980s. Most lung, skin, and bone infections were staphylococcal in the preprophylaxis era. On prophylaxis staphylococcal infections are essentially confined to the liver, lymph nodes, and skin [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/4\">",
"     4",
"    </a>",
"    ]. Severe, resistant facial acne and painful inflammation of the nares are common infectious skin manifestations of S. aureus infection.",
"   </p>",
"   <p>",
"    Burkholderia cepacia complex, which is a common cause of pneumonia with primarily endobronchial disease in patients with cystic fibrosis (CF), can cause pneumonia with nodular infiltrates in patients with CGD [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. Patients with CGD are prone to recurrent pulmonary infection with different strains of Burkholderia, unlike patients with CF who tend to have chronic infection with the same strain [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infants often present with Serratia marcescens bone and soft tissue infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/33\">",
"     33",
"    </a>",
"    ]. S. marcescens infections still occur in older children and adults with CGD, but the pattern of presentation is different [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/38\">",
"     38",
"    </a>",
"    ]. Osteomyelitis is rare, but disseminated abscesses and skin infections with large, poorly healing ulcers are common.",
"   </p>",
"   <p>",
"    Mycobacterial infections accounted for almost 6 percent of pneumonias in American CGD surveys in 2000 and 2007 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/4,39\">",
"     4,39",
"    </a>",
"    ]. A high incidence of tuberculosis was observed in CGD patients living in areas endemic for TB [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Draining skin lesions at sites of BCG vaccination are seen in CGD patients, although these infections rarely disseminate. However, dissemination of BCG may be strain-dependent, since numerous cases of disseminated BCG have been reported in particular countries where different strains are found [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Granulibacter bethesdensis is an environmental organism that can cause fever, weight loss, and necrotizing pyogranulomatous lymphadenitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Fatal bacteremia has been reported as well [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bacteremia is uncommon, but when it occurs, is usually due to the following organisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Burkholderia cepacia complex [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/36,46-48\">",
"       36,46-48",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      S. marcescens, which is also a common cause of bacterial osteomyelitis [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Chromobacterium violaceum, a gram negative rod found in brackish water, especially in the southeastern United States [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/49\">",
"       49",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infection with catalase-negative organisms is uncommon, but severe chronic recurrent Actinomycosis has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/50\">",
"     50",
"    </a>",
"    ]. All patients in one series presented with a prolonged history of fever and clinical signs of infection without an obvious focus. Sites of infection were cervicofacial, hepatic,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Fungal infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fungal infections were previously the leading causes of mortality in CGD [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/4\">",
"     4",
"    </a>",
"    ], even though the rate of fungal infections is lower than bacterial infections. Fungal infections typically begin in the lung after inhalation of spores or hyphae. The resulting pneumonia may spread locally to ribs and spine or metastatically to brain. The frequency and mortality of fungal infections have been markedly reduced since the advent of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/15/20730?source=see_link\">",
"     itraconazole",
"    </a>",
"    prophylaxis and the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/60/33737?source=see_link\">",
"     posaconazole",
"    </a>",
"    for treatment of filamentous fungal infections (eg, Aspergillus). However, fungal infections continue to occur, even in those on azole antifungal prophylaxis. Frequently and expectedly, the organisms that break through azole prophylaxis are resistant and require aggressive diagnosis and therapy. A major recognition has been that the organisms frequently determined morphologically to be Aspergillus fumigatus are in fact non-fumigatus Aspergillus species that require molecular diagnosis. Many of these organisms are more virulent than A. fumigatus and require combination antifungal therapy and may require surgical management [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Similarly, morphologic diagnosis can be misleading for organisms often thought to be Paecilomyces variotti, which are in fact more treatment refractory than Geosmithia argillacea [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bony involvement by fungi typically occurs by direct extension from the lung. Aspergillus nidulans, an organism that infects CGD patients almost exclusively, causes a significantly higher rate of osteomyelitis and mortality than other fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/32,55,56\">",
"     32,55,56",
"    </a>",
"    ]. Penicillium piceum is a relatively non-pathogenic fungus that can produce lung nodules and osteomyelitis in CGD [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/57\">",
"     57",
"    </a>",
"    ]. In contrast, infections with Zygomycosis are rare in patients with CGD and are typically associated with iatrogenic immune suppression [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     INFLAMMATORY AND OTHER MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CGD are also prone to granulomata of various organs, growth retardation, chronic pulmonary disease, and autoimmune disorders. In contrast to many other immunodeficiencies, CGD is probably not associated with an increased incidence of neoplasia, although several cancers have been identified in patients with CGD [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Granulomata",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CGD are prone to the formation of granulomata. These can affect any hollow viscus, but are especially problematic in the gastrointestinal and genitourinary tracts [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/34\">",
"     34",
"    </a>",
"    ]. Other tissues and organs, such as the retina, liver, lungs, and bone, may also be affected by granulomata [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/60\">",
"     60",
"    </a>",
"    ]. The reasons for granuloma formation in CGD are unknown. CGD cells fail to degrade chemotactic and inflammatory signals normally and this may lead to persistent and exuberant inflammation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Gastrointestinal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal (GI) manifestations of CGD include abdominal pain, diarrhea, colitis, proctitis, strictures, fistulae, and obstruction. In a series of 140 CGD patients, 43 percent of X-linked and 11 percent of autosomal recessive CGD patients had GI manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/61\">",
"     61",
"    </a>",
"    ]. All patients with confirmed inflammatory bowel disease complained of abdominal pain. Diarrhea was reported in 39 percent and nausea and vomiting in 24 percent. Thirty-five percent had GI obstruction (gastric, esophageal, duodenal, and other).",
"   </p>",
"   <p>",
"    Sixty-five percent of the patients in this series with GI involvement had either granulomatous or ulcerative colonic lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/61\">",
"     61",
"    </a>",
"    ]. Crohn's disease and ulcerative colitis were diagnosed in only 20 percent of those with inflammatory bowel lesions. The granulomata in CGD IBD were characterized by sharply defined histiocyte aggregates with surrounding lymphocytic inflammation, unlike the poorly formed granulomata seen in Crohn's disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Hepatic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver abnormalities were frequently identified in a CGD cohort of 194 patients: liver enzymes were elevated in 73 percent, 25 percent had persistent elevations of alkaline phosphatase, and drug-induced hepatitis was reported in 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/62\">",
"     62",
"    </a>",
"    ]. In patients with abnormal liver enzymes who underwent liver biopsy, histology revealed granulomata in 75 percent and lobular hepatitis in 90 percent.",
"   </p>",
"   <p>",
"    Eighty percent of patients in the series above had a portal venopathy that was often associated with splenomegaly [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/62\">",
"     62",
"    </a>",
"    ]. Liver abscesses and hepatomegaly were each seen in one-third of cases. Portal hypertension was an important risk factor for mortality and was strongly suggested by a decreasing platelet count over time [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Genitourinary",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a series of 60 CGD patients, approximately 40 percent of patients had urologic manifestations, including ureteral and urethral strictures, urinary tract infections, altered renal function, and bladder granulomata [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/64\">",
"     64",
"    </a>",
"    ]. All patients with urologic strictures had defects of the membrane component of the NADPH oxidase (gp91phox or p22phox).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Ophthalmic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chorioretinal lesions are described in up to one quarter of X-linked CGD patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/65\">",
"     65",
"    </a>",
"    ]. These lesions are mostly asymptomatic retinal scars associated with pigment clumping. These same lesions can be detected in gp91phox female carriers. Keratitis has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Pulmonary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic respiratory disease due to recurrent pulmonary infections is common. Findings on chest CT include bronchiectasis, obliterative bronchiolitis, and chronic fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/19,34\">",
"     19,34",
"    </a>",
"    ]. A clinical entity specific to CGD is mulch pneumonitis, so-called because patients with CGD can develop a characteristic syndrome of dyspnea, hypoxia, and fever leading to respiratory failure and death after inhalation of large burdens of fungal spores and hyphae, such as those found in mulch, hay, peat moss, or dirt [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/66\">",
"     66",
"    </a>",
"    ]. This syndrome is important to recognize since it is best treated with simultaneous administration of glucocorticoids and antifungals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Oral disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral manifestations of CGD include gingivitis, stomatitis, aphthous ulcerations, and gingival hypertrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Skin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-infectious skin manifestations of CGD include photosensitivity, granulomatous lesions, and vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Autoimmune disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune disorders are more common in CGD. Both discoid and systemic lupus erythematosus have been described, and occur with at least the same frequency in X-linked CGD female carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. Idiopathic thrombocytopenic purpura and juvenile idiopathic arthritis are also more frequent in CGD than in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/4\">",
"     4",
"    </a>",
"    ]. Other reported autoimmune diseases in patients with CGD include autoimmune pulmonary disease, IgA nephropathy, antiphospholipid syndrome, and recurrent pericardial effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Growth retardation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CGD commonly experience growth retardation. Failure to thrive is a frequent presenting symptom in young children. In one series of 94 patients, approximately 75 percent were below the population mean for height and weight at the time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/19\">",
"     19",
"    </a>",
"    ]. Thirty-five percent required nasogastric",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    parenteral nutritional supplementation. In another small series of 23 patients, approximately 20 percent were below the 10th percentile for height and weight [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/20\">",
"     20",
"    </a>",
"    ]. Growth often improves in late adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/70\">",
"     70",
"    </a>",
"    ]; many CGD patients attain their expected growth potential by adulthood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     McLeod syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gene coding for the Kell blood cell antigen system (XK) maps to Xp21, immediately adjacent to CYBB, the gene for gp91phox. Patients with deletions in the X-chromosome may delete portions of both genes (contiguous gene disorder) and thereby present with X-linked CGD and McLeod syndrome. McLeod syndrome causes acanthocytosis and low or absent expression of the erythrocyte blood group Kell antigens, eg, Kell(-). This may result in anemia, elevated creatine phosphokinase, and late-onset peripheral and central nervous system manifestations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27898?source=see_link&amp;anchor=H40#H40\">",
"     \"A primer of red blood cell antigens and antibodies\", section on 'McLeod phenotype'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/5/9305?source=see_link&amp;anchor=H14#H14\">",
"     \"Spiculated cells (echinocytes and acanthocytes) and target cells\", section on 'Blood group abnormalities'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/2/33833?source=see_link&amp;anchor=H1983242#H1983242\">",
"     \"Neuroacanthocytosis\", section on 'Mcleod syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Special care has to be taken when transfusing X-linked CGD patients to avoid Kell(+) transfusions into these Kell(-) patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. All X-linked CGD patients should be tested for Kell antigens. Those who test negative should have this noted on their medical record and wear medical identification jewelry stating that they must be given Kell(-) blood if they require a transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients suspected of having CGD should initially undergo neutrophil function testing. Positive findings should be confirmed by additional testing, such as immunoblot, followed by genotyping.",
"   </p>",
"   <p>",
"    A history of recurrent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    unusually severe infections, particularly abscesses and infections caused by the pathogens commonly associated with CGD, should prompt neutrophil function testing. Neonatal or early postnatal screening of potentially affected children is indicated if there is a family history of CGD. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Infections'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Typical presenting clinical features include splenomegaly, hepatomegaly, growth retardation, diarrhea, and abnormal wound healing with dehiscence, but these are neither necessary nor sufficient for the diagnosis.",
"   </p>",
"   <p>",
"    Certain abnormalities in routine laboratory tests are associated with the disease, although these are not required for diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypergammaglobulinemia, possibly due to chronic inflammation",
"     </li>",
"     <li>",
"      Anemia of chronic disease",
"     </li>",
"     <li>",
"      Elevated erythrocyte sedimentation rate and C reactive protein, usually in the presence of infection",
"     </li>",
"     <li>",
"      Hypoalbuminemia, found in 70 percent of patients with GI involvement and 25 percent without GI manifestations [",
"      <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/61\">",
"       61",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Neutrophil function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic tests for CGD rely on various measures of neutrophil superoxide production. These include direct measurement of superoxide production, cytochrome c reduction assay, chemiluminescence, nitroblue tetrazolium (NBT) reduction test, and dihydrorhodamine 123 (DHR) oxidation test.",
"   </p>",
"   <p>",
"    We prefer the DHR test because of its objectivity, relative ease of use, ability to distinguish between X-linked and autosomal forms of CGD, and the ability to detect gp91phox carriers [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. Other tests can provide reliable diagnosis of CGD, but either cannot distinguish carrier status or require significant operator experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Dihydrorhodamine 123 (DHR) test",
"    </span>",
"    &nbsp;&mdash;&nbsp;In this test, the non-fluorescent rhodamine derivative, DHR, is taken up by phagocytes and oxidized to a green fluorescent compound by products of the NADPH oxidase (",
"    <a class=\"graphic graphic_figure graphicRef68461 \" href=\"UTD.htm?26/6/26729\">",
"     figure 2",
"    </a>",
"    ). The sensitivity and quantitative nature of this assay make it possible to differentiate oxidase positive from oxidase negative phagocyte subpopulations in CGD carriers and identify deficiencies in gp91phox and p47phox. DHR testing can also be quantitated to allow for allocation of cellular response into more and less impaired subgroups. The degree of residual superoxide production as measured by DHR testing provides important prognostic information that dovetails with genetic information [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H36\">",
"     'Genetic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other conditions that affect the neutrophil respiratory burst include myeloperoxidase deficiency and SAPHO (the syndrome of synovitis, acne, pustulosis, hyperostosis, as osteitis), giving abnormal DHR test results but normal measures of extracellular superoxide production (eg, cytochrome c reduction or NBT tests) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Several reference laboratories in the United States and around the world offer these assays.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Nitroblue tetrazolium (NBT) test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oldest and best-known laboratory test for CGD is the nitroblue tetrazolium (NBT) test. This provides a simple and rapid (but largely qualitative) determination of phagocyte NADPH oxidase activity. Superoxide produced by normal peripheral blood neutrophils stimulated in vitro reduces yellow NBT to dark",
"    <span class=\"nowrap\">",
"     blue/black",
"    </span>",
"    formazan, which forms a precipitate in the cells. Normal phagocyte oxidase activity will result in at least 95 percent positive cells in this assay. X-linked carriers can be identified with this test. Test limitations include a higher rate of false negative results and operator subjectivity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Confirmatory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Techniques such as immunoblot can be used to confirm the diagnosis of CGD. Failure to detect p47phox or p67phox proteins indicates autosomal recessive mutations in the corresponding genes. The limitation of this technique is that it cannot distinguish between the X-linked gp91phox defect and the p22phox autosomal recessive defect, since expression of these two proteins on the cell membrane is mutually dependent. If there is a deficiency of either one of them, the other is also absent in immunoblot analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical history usually suggests autosomal recessive or X-linked disease, based on sex, consanguinity, age at presentation, and severity. A diagnosis of CGD based on abnormal neutrophil function should be followed by a confirmatory test to verify that the patient really does have CGD before genetic counseling is provided. Sequencing of the patient's phagocyte oxidase (phox) genes to determine the exact molecular defect is recommended but not necessary. Genetic testing is available through specialized commercial laboratories and selected tertiary referral centers (commercial laboratories in the United States include: GeneDx in Maryland, Correlagen Diagnostics in Massachusetts, and ARUP Laboratories in Utah; tertiary centers include: NIH in Bethesda, Great Ormand Street Hospital in London, Necker Hospital in Paris, and Garrahan Hospital in Buenos Aires).",
"   </p>",
"   <p>",
"    Genetic testing is increasingly important in the risk profiling of X-linked CGD. Mutations in the gene encoding gp91phox (CYBB) are usually either missense (replacement of the correct amino acid with an incorrect one but preserving protein synthesis) or nonsense (replacement of an amino acid with a stop codon leading to protein truncation and usually abrogating protein synthesis). Nonsense mutations generally lead to more severe CGD with diminished survival. Missense mutations that are in amino acids 1 to 309 are associated with residual superoxide formation, slight DHR positivity, and better survival. In contrast, mutations at amino acids 310 and beyond affect critical protein functional domains and lead to complete loss of DHR activity, more severe CGD, and diminished survival [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the precise mutation of a family member with CGD is known, then chorionic villus sampling can be performed to obtain a sample for genotyping of the fetus. Another testing option is to sample fetal blood and perform a DHR or NBT test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of CGD mainly involves disorders associated with recurrent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    unusually severe infections, particularly those caused by the pathogens commonly associated with the disease. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Infections'",
"    </a>",
"    above.) However, it is usually possible to differentiate between these diseases and CGD when the entire clinical picture is examined. The differential diagnosis may consider:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cystic fibrosis",
"     </li>",
"     <li>",
"      Hyper IgE syndrome",
"     </li>",
"     <li>",
"      Glucose 6-phosphate dehydrogenase (G6PD) deficiency",
"     </li>",
"     <li>",
"      Glutathione synthetase (GS) deficiency",
"     </li>",
"     <li>",
"      Crohn's disease (in patients with inflammation limited to the rectum)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Cystic fibrosis patients may develop Burkholderia cepacia complex infections. However, the infections in patients with cystic fibrosis are limited to the lung and typically occur in the setting of significant bronchiectasis, which is not as common in patients with CGD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=see_link\">",
"     \"Cystic fibrosis: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hyper IgE syndrome patients develop staphylococcal infections and may develop Aspergillus in the lung. However, the Aspergillus infections occur only in the setting of preexisting lung cysts, which are not common in patients with CGD. Also, hyper IgE patients have characteristic facies and markedly elevated IgE levels, whereas CGD patients do not. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32153?source=see_link\">",
"     \"Hyperimmunoglobulin E syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    G6PD deficiency and GS deficiency affect the neutrophil respiratory burst and increase susceptibility to bacterial infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/78-80\">",
"     78-80",
"    </a>",
"    ]. G6PD deficiency is most often associated with some degree of hemolytic anemia, whereas CGD is not. Severe GS deficiency is also associated with hemolytic anemia, in addition to 5-oxoprolinuria, acidosis, and mental retardation. These disorders are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14280?source=see_link\">",
"     \"Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In vitro the respiratory burst may also be inhibited by diverse pathogens, including Legionella pneumophila, Toxoplasma gondii, Chlamydia, Entamoeba histolytica, and Ehrlichia risticii. Human granulocytic ehrlichiosis infection depresses the respiratory burst by downregulating gp91phox [",
"    <a class=\"abstract\" href=\"UTD.htm?10/36/10826/abstract/81\">",
"     81",
"    </a>",
"    ]. This effect is not diagnostically significant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/19/8498?source=see_link\">",
"       \"Patient information: Chronic granulomatous disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic granulomatous disease (CGD) is a genetically heterogeneous condition characterized by recurrent life-threatening bacterial and fungal infections and granuloma formation. Most patients are diagnosed before the age of five. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CGD is caused by defects in phagocyte NADPH oxidase (phox), the enzyme complex responsible for the phagocyte respiratory burst. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mutations in all five genes (gp91phox, p47phox, p22phox, p67phox, and p40phox) that make up the NADPH oxidase complex account for all of the known cases of CGD. Most mutations are X-linked (gp91phox). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Genetic defects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Female carriers generally do not have an increased rate of infections, but they are more predisposed to certain inflammatory manifestations associated with CGD. However, highly lyonized females can develop typical CGD infections. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'X-linked carriers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with CGD typically experience recurrent infections caused by bacterial and fungal pathogens. The frequent sites of infection are lung, skin, lymph nodes, and liver. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The overwhelming majority of infections in patients with CGD living in North America are due to five organisms: Staphylococcus aureus, Burkholderia (Pseudomonas) cepacia complex, Serratia marcescens, Nocardia, and Aspergillus. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Organisms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with CGD are prone to the formation of granulomata that are especially problematic in the gastrointestinal and genitourinary tracts. Colitis is a common gastrointestinal manifestation. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Inflammatory and other manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A neutrophil function test is the initial diagnostic test performed. A positive finding should be confirmed by additional testing, such as immunoblot or genotyping. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/1\">",
"      Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/2\">",
"      Reeves EP, Lu H, Jacobs HL, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/3\">",
"      Teimourian S, Zomorodian E, Badalzadeh M, et al. Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease. Br J Haematol 2008; 141:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/4\">",
"      Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/5\">",
"      Roos D. X-CGDbase: a database of X-CGD-causing mutations. Immunol Today 1996; 17:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/6\">",
"      Roos D, de Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87:1663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/7\">",
"      Rae J, Newburger PE, Dinauer MC, et al. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am J Hum Genet 1998; 62:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/8\">",
"      Ariga T, Furuta H, Cho K, Sakiyama Y. Genetic analysis of 13 families with X-linked chronic granulomatous disease reveals a low proportion of sporadic patients and a high proportion of sporadic carriers. Pediatr Res 1998; 44:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/9\">",
"      Matute JD, Arias AA, Wright NA, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 2009; 114:3309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/10\">",
"      Kurkchubasche AG, Panepinto JA, Tracy TF Jr, et al. Clinical features of a human Rac2 mutation: a complex neutrophil dysfunction disease. J Pediatr 2001; 139:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/11\">",
"      Accetta D, Syverson G, Bonacci B, et al. Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol 2011; 127:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/12\">",
"      Bustamante J, Arias AA, Vogt G, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 2011; 12:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/13\">",
"      Hartl D, Lehmann N, Hoffmann F, et al. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J Allergy Clin Immunol 2008; 121:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/14\">",
"      Romani L, Fallarino F, De Luca A, et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008; 451:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/15\">",
"      De Ravin SS, Zarember KA, Long-Priel D, et al. Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease. Blood 2010; 116:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/16\">",
"      Brown KL, Bylund J, MacDonald KL, et al. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol 2008; 129:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/17\">",
"      Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, et al. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4. Blood 2009; 113:2047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/18\">",
"      Suliaman F, Amra N, Sheikh S, et al. Epidemiology of chronic granulomatous disease of childhood in Eastern Province, Saudi Arabia. Pediatr Asthma Allergy Immunol 2009; 22:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/19\">",
"      Jones LB, McGrogan P, Flood TJ, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol 2008; 152:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/20\">",
"      Kobayashi S, Murayama S, Takanashi S, et al. Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan. Eur J Pediatr 2008; 167:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/21\">",
"      Martire B, Rondelli R, Soresina A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol 2008; 126:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/22\">",
"      Soler-Palac&iacute;n P, Margareto C, Llobet P, et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr) 2007; 35:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/23\">",
"      Esfandbod M, Kabootari M. Images in clinical medicine. Chronic granulomatous disease. N Engl J Med 2012; 367:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/24\">",
"      Repine JE, Clawson CC, White JG, Holmes B. Spectrum of function of neutrophils from carriers of sex-linked chronic granulomatous disease. J Pediatr 1975; 87:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/25\">",
"      Anderson-Cohen M, Holland SM, Kuhns DB, et al. Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation. Clin Immunol 2003; 109:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/26\">",
"      Wolach B, Scharf Y, Gavrieli R, et al. Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB. Blood 2005; 105:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/27\">",
"      Roesler J. Carriers of X-linked chronic granulomatous disease at risk. Clin Immunol 2009; 130:233; author reply 234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/28\">",
"      Lewis EM, Singla M, Sergeant S, et al. X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation. Clin Immunol 2008; 129:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/29\">",
"      Brandrup F, Koch C, Petri M, et al. Discoid lupus erythematosus-like lesions and stomatitis in female carriers of X-linked chronic granulomatous disease. Br J Dermatol 1981; 104:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/30\">",
"      Kragballe K, Borregaard N, Brandrup F, et al. Relation of monocyte and neutrophil oxidative metabolism to skin and oral lesions in carriers of chronic granulomatous disease. Clin Exp Immunol 1981; 43:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/31\">",
"      Dorman SE, Guide SV, Conville PS, et al. Nocardia infection in chronic granulomatous disease. Clin Infect Dis 2002; 35:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/32\">",
"      Segal BH, DeCarlo ES, Kwon-Chung KJ, et al. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 1998; 77:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/33\">",
"      Galluzzo ML, Hernandez C, Davila MT, et al. Clinical and histopathological features and a unique spectrum of organisms significantly associated with chronic granulomatous disease osteomyelitis during childhood. Clin Infect Dis 2008; 46:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/34\">",
"      Towbin AJ, Chaves I. Chronic granulomatous disease. Pediatr Radiol 2010; 40:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/35\">",
"      Ramanuja S, Wolf KM, Sadat MA, et al. Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn disease. Ann Allergy Asthma Immunol 2005; 95:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/36\">",
"      O'Neil KM, Herman JH, Modlin JF, et al. Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr 1986; 108:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/37\">",
"      Greenberg DE, Goldberg JB, Stock F, et al. Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center. Clin Infect Dis 2009; 48:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/38\">",
"      Friend JC, Hilligoss DM, Marquesen M, et al. Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease. J Allergy Clin Immunol 2009; 124:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/39\">",
"      Bustamante J, Aksu G, Vogt G, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol 2007; 120:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/40\">",
"      Lau YL, Chan GC, Ha SY, et al. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis 1998; 26:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/41\">",
"      Lee PP, Chan KW, Jiang L, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J 2008; 27:224.",
"     </a>",
"    </li>",
"    <li>",
"     Rosenzweig S, personal communication, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/43\">",
"      Greenberg DE, Ding L, Zelazny AM, et al. A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog 2006; 2:e28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/44\">",
"      Greenberg DE, Shoffner AR, Zelazny AM, et al. Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease. Emerg Infect Dis 2010; 16:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/45\">",
"      L&oacute;pez FC, de Luna FF, Delgado MC, et al. Granulibacter bethesdensis isolated in a child patient with chronic granulomatous disease. J Infect 2008; 57:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/46\">",
"      Sirinavin S, Techasaensiri C, Pakakasama S, et al. Hemophagocytic syndrome and Burkholderia cepacia splenic microabscesses in a child with chronic granulomatous disease. Pediatr Infect Dis J 2004; 23:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/47\">",
"      Hisano M, Sugawara K, Tatsuzawa O, et al. Bacteria-associated haemophagocytic syndrome and septic pulmonary embolism caused by Burkholderia cepacia complex in a woman with chronic granulomatous disease. J Med Microbiol 2007; 56:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/48\">",
"      Lacy DE, Spencer DA, Goldstein A, et al. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J Infect 1993; 27:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/49\">",
"      Macher AM, Casale TB, Fauci AS. Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States. Ann Intern Med 1982; 97:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/50\">",
"      Reichenbach J, Lopatin U, Mahlaoui N, et al. Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clin Infect Dis 2009; 49:1703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/51\">",
"      Vinh DC, Shea YR, Sugui JA, et al. Invasive aspergillosis due to Neosartorya udagawae. Clin Infect Dis 2009; 49:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/52\">",
"      Vinh DC, Shea YR, Jones PA, et al. Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis 2009; 15:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/53\">",
"      De Ravin SS, Challipalli M, Anderson V, et al. Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. Clin Infect Dis 2011; 52:e136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/54\">",
"      Machouart M, Garcia-Hermoso D, Rivier A, et al. Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis. J Clin Microbiol 2011; 49:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/55\">",
"      Sponseller PD, Malech HL, McCarthy EF Jr, et al. Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg Am 1991; 73:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/56\">",
"      Henriet SS, Verweij PE, Warris A. Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interaction. J Infect Dis 2012; 206:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/57\">",
"      Santos PE, Piontelli E, Shea YR, et al. Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease. Med Mycol 2006; 44:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/58\">",
"      Vinh DC, Freeman AF, Shea YR, et al. Mucormycosis in chronic granulomatous disease: association with iatrogenic immunosuppression. J Allergy Clin Immunol 2009; 123:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/59\">",
"      Lugo Reyes SO, Suarez F, Herbigneaux RM, et al. Hodgkin lymphoma in 2 children with chronic granulomatous disease. J Allergy Clin Immunol 2011; 127:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/60\">",
"      Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol 2008; 28 Suppl 1:S67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/61\">",
"      Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/62\">",
"      Hussain N, Feld JJ, Kleiner DE, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007; 45:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/63\">",
"      Feld JJ, Hussain N, Wright EC, et al. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Gastroenterology 2008; 134:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/64\">",
"      Walther MM, Malech H, Berman A, et al. The urological manifestations of chronic granulomatous disease. J Urol 1992; 147:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/65\">",
"      Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr 1999; 134:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/66\">",
"      Siddiqui S, Anderson VL, Hilligoss DM, et al. Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis 2007; 45:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/67\">",
"      Manzi S, Urbach AH, McCune AB, et al. Systemic lupus erythematosus in a boy with chronic granulomatous disease: case report and review of the literature. Arthritis Rheum 1991; 34:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/68\">",
"      Cale CM, Morton L, Goldblatt D. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol 2007; 148:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/69\">",
"      De Ravin SS, Naumann N, Cowen EW, et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol 2008; 122:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/70\">",
"      Buescher ES, Gallin JI. Stature and weight in chronic granulomatous disease. J Pediatr 1984; 104:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/71\">",
"      Marsh WL, Oyen R, Nichols ME, Allen FH Jr. Chronic granulomatous disease and the Kell blood groups. Br J Haematol 1975; 29:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/72\">",
"      Frey D, M&auml;chler M, Seger R, et al. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. Blood 1988; 71:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/73\">",
"      Vowells SJ, Sekhsaria S, Malech HL, et al. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 1995; 178:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/74\">",
"      Vowells SJ, Fleisher TA, Sekhsaria S, et al. Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease. J Pediatr 1996; 128:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/75\">",
"      Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363:2600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/76\">",
"      Mauch L, Lun A, O'Gorman MR, et al. Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD. Clin Chem 2007; 53:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/77\">",
"      Ferguson PJ, Lokuta MA, El-Shanti HI, et al. Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum 2008; 58:3264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/78\">",
"      Roos D, van Zwieten R, Wijnen JT, et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 1999; 94:2955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/79\">",
"      Whitin JC, Cohen HJ. Disorders of respiratory burst termination. Hematol Oncol Clin North Am 1988; 2:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/80\">",
"      Ristoff E, Mayatepek E, Larsson A. Long-term clinical outcome in patients with glutathione synthetase deficiency. J Pediatr 2001; 139:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/36/10826/abstract/81\">",
"      Banerjee R, Anguita J, Roos D, Fikrig E. Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol 2000; 164:3946.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3925 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-08F90C6EF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10826=[""].join("\n");
var outline_f10_36_10826=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H39\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Activation of NADPH oxidase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Respiratory burst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Genetic defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Innate immune receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Enhanced inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Tryptophan catabolism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Inflammatory mediators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Efferocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      X-linked carriers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Sites of infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Organisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bacterial infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Fungal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      INFLAMMATORY AND OTHER MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Granulomata",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Hepatic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Genitourinary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Ophthalmic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Pulmonary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Oral disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Autoimmune disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Growth retardation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      McLeod syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Neutrophil function tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Dihydrorhodamine 123 (DHR) test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Nitroblue tetrazolium (NBT) test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Confirmatory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Genetic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3925\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3925|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/13/40151\" title=\"figure 1\">",
"      NADPH oxidase system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/6/26729\" title=\"figure 2\">",
"      DHR test",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27898?source=related_link\">",
"      A primer of red blood cell antigens and antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11465?source=related_link\">",
"      Chronic granulomatous disease: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32153?source=related_link\">",
"      Hyperimmunoglobulin E syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=related_link\">",
"      Mendelian susceptibility to mycobacterial diseases (MSMD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14280?source=related_link\">",
"      Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/2/33833?source=related_link\">",
"      Neuroacanthocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/19/8498?source=related_link\">",
"      Patient information: Chronic granulomatous disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=related_link\">",
"      Primary disorders of phagocytic function: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/5/9305?source=related_link\">",
"      Spiculated cells (echinocytes and acanthocytes) and target cells",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_36_10827="Common agoraphobic situations";
var content_f10_36_10827=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F77033&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F77033&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common agoraphobic situations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Waiting in line",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crowds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Being home alone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Grocery stores",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shopping malls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Driving",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Restaurants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Movie theaters",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wide open spaces",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hairdressing appointments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doctor or dentist appointments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Being away from home",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Public transportation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Flying",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10827=[""].join("\n");
var outline_f10_36_10827=null;
var title_f10_36_10828="Counseling women with a prior cesarean delivery";
var content_f10_36_10828=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Counseling women with a prior cesarean delivery",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Early pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Documentation of type(s) of prior uterine incision(s)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Identification and discussion of potential risk factors associated with TOLAC/VBAC and ERCD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Discussion and documentation of risks and benefits of TOLAC and ERCD vis-&agrave;-vis evidenced-based reports:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        - Success and failure rates of TOLAC/VBAC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        - Incidence of uterine rupture and factors that increase risks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        - Future reproductive plans and risks with multiple CDs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        - Maternal and perinatal risks with uterine rupture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        - Neonatal risks associated with TOLAC and ERCD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Availability of hospital resources for TOLAC/VBAC or ERCD and alternatives if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        - Immediate 24/7 availability&mdash;facility, anesthesia, surgeon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        - Increased risks for transfusions or hysterectomy, eg, placenta accreta, increta, percreta",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Throughout pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Reassessment of plans if circumstances arise that may alter projected risks of TOLAC versus ERCD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Flexibility of patient and provider for plan of delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        General considerations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Documentation of counseling and management plans in the record",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &bull; Written and signed informed consent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10828=[""].join("\n");
var outline_f10_36_10828=null;
var title_f10_36_10829="Major causes of wheeze";
var content_f10_36_10829=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67704&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67704&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of wheezing based on anatomic site of obstruction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Extrathoracic upper airway obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Postnasal drip syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Paroxysmal vocal cord motion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypertrophied tonsils",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Supraglottitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Laryngeal edema",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Laryngostenosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Postextubation granuloma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Retropharyngeal abscess",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Benign airway tumors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Anaphylaxis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Malignancy",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Obesity",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Klebsiella rhinoscleroma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mobile supraglottic soft tissue",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Relapsing polychondritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Laryngocele",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Abnormal arytenoid movement",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Vocal cord hematoma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bilateral vocal cord paralysis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cricoarytenoid arthritis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Granulomatosis with polyangiitis (Wegener's)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Intrathoracic upper airway obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tracheal stenosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Foreign body aspiration",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Benign airway tumors",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Malignancies",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Intrathoracic goiter",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tracheobronchomegaly",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Acquired tracheomalacia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Herpetic tracheobronchitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Right sided aortic arch",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Lower airway obstruction",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Asthma",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            COPD",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary edema",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aspiration",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary embolism",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bronchiolitis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cystic fibrosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Carcinoid syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bronchiectasis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lymphangitic carcinomatosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Parasitic infections",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10829=[""].join("\n");
var outline_f10_36_10829=null;
var title_f10_36_10830="Infant humeral fracture";
var content_f10_36_10830=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    9 week old with mid left humerus fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 216px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADYAT4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD2fxNqDRR7bW2QO3SSb/CuQu9SXToRcahcDzsHGBj8hVXx34mnn1n7LY7Y44vvSSHGTiuD1zVbO1tHeRpL68PI5yqmgCp4x1u61W1mM832TTF+ZnYfNIf614v4t8SHVI0sLEGPT4WO0Hq59TV7xrqGoaixa7kYRdFhXhVrjAMkD044oAbinYp4SnbPagCIKT0FLtNTqvtTtme1AFfa3pTgnFT7acE44oArGL3pRHgVY2H0o2H0oArlKTZVkrjrSbe/agCvso2VY2UbaAKxTt69/SljDxMjo2JAeCKsbaQj060AdRouvZAW44kTgkd666x1JZrR135Oc15THujcMp5FakFzJEPNt3PP3loA9W0TXn024Vid0R6j0r0601GG5gSSJ9ySLkexr5pttcdGAuF3D1FdTpHi/wCxLEyyHyx1UmgD3aw1KS2lGfuq2T7itC+1qJEeYSqzrnYAOefWvOLPxLBewiWKRORyN1S3F/HJGSGB96ANCGUm8DP1YM2azp797a8S5RyHU9u4qkmoATjJ6Aj9Kzrq58yYA/lQB7V4L1eO/khZD83Uj3r0VZSrgjoOK+YfA3iNNM14Bn/ducYz3r6G0W++2W6uWGSM0AdpZn5NpOe9WazLCYsgPfoa0gQRkdKAFNZl/OPLcH8K0Sc9KxdTAXdjp1NAHH61yr5xzzXmmoDdJIsuCN3HNel6zhkYIeo715PqxZbiYE4YOaAOe1oCMYxknvXl/jF99jIxPtXo2uSh4WB4PavLvF0w+ySxd9wNAHG/zoo+vpRQAUlLSDrQB9FWkdxqd09xqczyqffGTU97bwRWrKiBQf7x5NOS5jijCRAcCsPW9UEcEhZugoA4vxY8So/3fb3rhwu4g4xWnqt497csWJ2A8Cqyx560AQqnapPL+lTrGOlPWOgCusdPWPjOKsLFUnlenSgCrsHoKNntVryhThEPSgCns9qAmegq4Ihk8UojwKAKXl57ZoKYHAq95Q9KQxDPQ0AUxHkcik8selXPKHoaPKAI4oAptGO4pvlL6VeaIZpBEKAKRjAHSiEtE+fz9KtmLnGOKYYhmgAZVdcoMMetLIga2XbzTNhUgqe9W7Yq6NG3DHlaAK1ldyWb7lc49K6e08RTRQqxYPEvY9RXPfZiTjGD79KAqwHGWIPUL0oA7ZNZhlZHV9u71qO41qKF5HLDGCBXDs7jiP5V7VNIC0C7znJ55oA29FvDcaqsjEqFORzX0j8P9caa3SJ2wwUbTXy/oTg3IQcAnGe9ev8AhG+aORQzFeADj0oA+l9FvhIdpYbhXQRS4HXivMPD139pMQDeXMPuv/eHpXV2upPHMI5VI9R6UAdJ5uWK85rL1JyxfoQBTE1KIy4Qkk+vaqlzODHNj0NAHLa22VO015ZrkmJZs4zuPNelaxKuxsY615N4nnAuJRnHegDk9ZuMqRuHtXmPiOfz7h1zwo5rrvEOoKkbkHkVwN0WMckz9ZDwKAM+iiigAoUc0U7vQB7vd3Cw2/DfNniuG8UX+9BEjZY9am13XA8vlwnOK5qUvOxd6AKyIe/JJqZYz6VLHFUwjoAhWIVKsYxU0aVMsXzcUAQKg9KcIuatrHS+WPU0AVRDlc46GlMfPQVa8vp2p4j3Dp0oApiLjNHlgmruzPNHld6AKZiHvTTGOlXtmRmk8vg0AUvKFBi96ulBxSeWKAKRj/Gk8v2q95YpCgoApGLio2j55FaBjHrTGjoAz2jFM8ods1eaPmk8v2oAourFcbmqPD1eaPnFRmOgCmVPTJqeNN0W08lelStHQgK/d6jrQBJpURF9Hj15r1DSAVVWXhuMV5zpqhb2PHQmvUtIj3RLnOAPSgDufD2oldgySwIPWvULG4S7EBJHmFQQ3r7GvHLMEEbCVIPBru/D96xityzZIoA1Wmktr9zzuD8itaSdZI5ivI28iuY1PUF+0zbvlYHg+1WLe/TyyQ4G5KAMbW5Pkfrj2rxvxpdCC5LlsDnPNd/4j1hURtjBiOMYrxjxpPLdMXcnaCTigDltWuTdTl8Yj/nWDfMZHHZR0FaEzbsYyF9KoTr89AFMjikqV14qMrxQAlO70ynL1oA6IRktycn1qVY6kVOKmROKAGJGcVNHHxT0TiplXHSgBiR+tPVB6VOiVIqZoAhEdP2N6VYVKeEG7pQBVEZ7D60/yvTpVtYxmnGP2oApeX60qwnOR0q4Y/ajyxQBT8v8KQxsOnNXTGMepo2ZFAFHy2PXil8o+tXdoHajywfagCkIT600xZ4q+YhSFQO3NAFAxYGMUwp7VfZM8YphTnFAFAp7VG6Cr+zJII4HSo2UDPFAFDYD1HNIY+tXClMZfl3UAVPKNHlGrO3HWnbfagCKwBF3GPRq9a0aLMaEgn5R+FeX2cebyDHdua9b0iICJAD0UUAbNrGy5xzxXSaLkxIFAyHrGtwe3T1rd0Xq6Lw3WgCvrMX+mzKScHk1JbJvhiYjjkGrGvqPtqnGA680unMotmTqyvxQB59rtqBLIFz96vPfFFiVhfeAD1r1fxHI6XMqQgKW5LHtXm3iCJpC28l+ozQB5bcY+6oyB371QdSpwa17uLZO6AdDVGQc4oAoMKhdauOuDUMlAFXbTo1yxzQ/enQr8xzQB1qL8lTIM0qpkccU7YQMcHNAEijsKkUVGvGKmXnFAEqetSqOc9qjQgZBqUEYx2oAkU89BTx94VGCRTtw9aAJcrnp+lG4UzIoJoAfnNGQOtMz70hJzwRQBJuFG4UwH1xRmgB+RRkYpmaMigCQEY+tBHrUYNOBJPNAAVGPSon44xz60/J9aRsbT60ARGo25qQ1G3BoAjP36aw7VIRzmm4JPegBhGe1NIA9akIA470w5oAs6Uub6I+9et6SBsT5e1eVaMP9NX869a0lR5UfHJGc0AblsODjitnRl/0hh3K1lwJj5V/E1qaUdl7GCQQQRQBZ8QxDdbse64qro2UuHRhkkZFauuputYGwchsc1l6flL6Ptu4oAwPFEAF22R94V5/rseN+egr1LxdFt2uB7GvNtZQ7SMGgDyXWlEd64Hc1kS9a6HxHFi7yRzWDKPmoApyjmq71blHy1VcUAQuORTo+HOKZJRH98/SgDuF5zmnqDjIpgwOR3qRGxQA8YI+YU8Ieo59qQEcbu9SoMfd5oAYQc8jFSAmnBiPvDNLsycJzQAobNP4qE5HbFOycZHSgCXIpSeKhByM0ZJ6GgCTJPel3e1Qkkd6A3rQBNknpxRk9M1Fu6detLnqKAJNwzS5BqHOCKUNg0ATClzgcdai3Zo3HFADyTjjmmE9z1oyTSEkUADYwDTCQaOAD703jHvQAGkzxmimYOOtAA3TdSD7uaQkk80m7jGaANXw0nmarCvY9RXr2mgiPb6V5X4LUNrC5GcDNetWCdT1z2FAGvbA7R/Or1n8tzGQM4PWqkACrznPpVqEhZEI9RQBuasrSaeQf4WBzWHESJ4mA6N1rpLlC2nzdyUDCuZY4QMAeKAJ/FMe+0YkcjDCvL9bUkNXrWpx+fp5bOcpXlmrrhSCOec0AeU+KkxICPWuYl6iux8Ur8hNcfKPSgCo/WqzdKtSY/GqrdKAIXAwaYn3vwqRqag+c/SgDs0cdKmUgdqqo6jnGamRxnkUAWUZe9WEIAyp/Cq9vGZyPLHPvWzZaKZP9a/zHtQBTGHx0BpVhccoCRXSW+hoAu0Z+laNrpgQ42Z/CgDixk/fQkfSnfZZX5iRiPpXosemx7gTCv0xU4sIsfd2+wFAHl7wTqDmIgfSosOP4W/KvTriwQjBTI+lQ/wBlWbNnBGOmR1oA82Oe4wfpTSea9Ck0SEk7QpGfSq0+gx87gvPbFAHEdhg9/WlI7jmujn8ODkxnFZ9zo9xEM7gfQUAZYIBpS3JqSSBo+WQ8VGRz0GKAFQkjJPFKuPWmkEdOlKuMdaAF3DPFNY9qMCm4zQAUnAOc0j4A45ppGBQA7Az7VGTjrSk8YpDQAUp4IHrTOKXPNAHWeAId+ouepAr1jT4tkYGOcV5z8MoP+PiZhkZIr061XCCgC7EnHJNTgYxgE0xMlTUgHGTnNAHSQDfbjOctHjFcvOmFZeeK6ewfNvCfbbXP3i7biRcc7iKALShjYIx+6Rg15r4gQJPKvT5j+Vel2hB0wrycZxXnniyIJcn1YE0AeVeKVzC/sK4aftivQfEqf6PLnrivPpskD9aAK0npVVx2q09Vn6mgCCTgGmofmJ9qfJ0NRrw2PagDrUUswRVJPtW9pmhySjdKOD05rd0vRreNQAoLV0dpYBONooAwbPRzFgBM4rYtbFj1Xmt63tAMYXr3q3Haqp/+tQBlQW+3G35QK0Yo++MirQtx25/CrEUBHYUAV0RRxipgiFfmQk1YWIU7y1+tAFNlUn0HTGKj+zwMuGzkVbaMg9OKidKAK/2KAkhSQKjksIz/ABA1YaPcO4NRkHPtQBQm09gOF4+tZtxYt0ZevrW/I7IMA/hTEEkxxs3E8Zx0oA5K50xTlWXIqkfDjTt+6iI969GTSIsfvgC3tViO02KRGoCigDzuHwaOPtDMMdlNXB4Ut1GVUkfWu4azxySeaQW+3gL+NAHBy+GrY5IjPSse98M7Sdm4d69TNiJFO1c1UurBfukcn2oA8euNIuIg20ZFUpbeWMYZCK9TvdJJJAAFYF1pbq5GwNnigDhGphJ78V09zpqjIdAD9Kz5dIJP7vIoAyCcjOMU5FaR1VBlm4ArVt9CndjkZAroPDnhsLdrPKuVU5ANAHVeC9PNhpUQZfnfk12tnH8oLDn0rG06MkRg4AXsK3rfAHuaALCAewx2qUZPXuKhHUGnKxB5FAG1YORbqPf8qzdTBF2+e/Oau2Df6Jz1DVW1nBlVhwCDQAWDYsJCSCAa4bxim6RJMdcjNdtZsBp0m71xXI+K1/0Hd2VsUAeT+IseTICMnHWvOZgcntzXo/iJcxPg/wAJrzmfIJJ55NAFRx1qs/U1Zc8GqznmgCGXpUf8f4VJJzUa8saAPpm00xlUMQCOvSta3tlYfN+VX5Soj2qRg+lLaw5Zfl/GgBkNuyHheB1qz5NaMFu2D6ZqyLfOeBQBlxw4XjJFSJBitMWo6g0pttuAfzoAbp1qssTZAzUdxZJ/kV0Wn2yrZSEL8w7+tUp4yR6H0oA55rEOcI3NQPYyrn5CR7V0EkB3AjJ9qesbqvAB9qAOSnglTnYQPpVSQHecgj8K66UDcQRz6CnRW0cuN8fHvQBylvaGQ/Pnb71qQxLENoB/CumWztGUL5eGqymmWnBKkfQ0AcwkWPvgZpxXIwoAHf3rqDpVqUJVsexHNNGkwn5g649KAOZMOSAg6irUFkgAMnOe1dJb6NCGzvHvzVibSY9q7G/GgDmmtyQNgAHtVa6tVxtbqe3euyj0xYYtpwwbjNUbrRMgYbLe/egDgLi1w5GOO1Z81mpJyOvHSuq1Czlt3xKhC+uKy54cqT0GaAOVuNOQy5IBHpioF06LOQmT7V0M0XzbcYB701IAi5AOT+VAGXFaDZ8qqB9Oa07C3UIemfQVKkQLg8VPDDsk3Lj3oAkiiEbBlx0q9ExOARj3psaBgNtOICnHODQBOpHHOSKd1+tRoSe4x6VID60Aamn/APHq4Y4+ao9SUPZZJyVbiiyI2HnqaW5G5XXsRQBWiGNMPua5zXl83Tp1xyORXUIcWYjPGOtc9qmBHIozlgf5UAeM68D5L59DXnNz1I9zXpOvKSGGOmc151driZx70AZ7d6rydTVmReDVaQc0AQPUa8OalcE1GAd5NAH2nHo0Y+YZLZ7mtC1sFJClRx1xW15AwTjgVZgtlVd2MZ70AZaWYVflz9KXySCQVxitd41VBgY/rUU+MkDkGgDPEYAzjijYCOnWrIUngDilVP4T09aANGxiJs8DkEZ+lUZoOTkc1rWA22xxycVXEauzbxyPegDHePbjINRyAAjPBHetKYANhQc+npVN0j3kO59z70AUFjZiSACM96sxgAH+QqYz26LhgM9veof7RhQhkjx9RQBYQEgFV59asBXwCTg49Kz31tsYWIbaadamxhRgUAaallHAJb1xUo8wgExn8qwzqszscyMo9gKeL8scb2P40AdLDFIeigA8mrR3fIpxwK5+1umJUmRgPrViS4KHdliT05oA1ZpsMI2X5T3NUWkZrjljhehFZF5dyTNyTkdOav6S+UKvxjnJoAmnMUieVcqrDuT2rntS0UgNLZnzFP8AD6V0N+lvcJsk3I/QOtZ/kzwJkOWUdCKAOOlhKyBJIyrD1FLJEpVfmHPpXXF4bldl3GpPZgOazLvQS2XsZFfP8B4xQBhLEvQfnTgqjof0p9xDLbsUnjaP3I4qBZABgmgCzCQvf86lLBhVMMSeMY75qdGzjFAEqIM81OoBHpioQQevT1qUHjjvQBpWaBk981a8lWkXc3ArISRlcbSQOlW8MFJLE+1ADdSjALKrfLjgiub1BTvAPXGK6C6XdFt3YK881z2oMVZS3IzwaAPKfE6hJ51AxjNeZ3v+vf616j4uObqavL73ieT60AZ8nXFVZOtWZPvGqz9TQBC1R5GTUjVEAdxoA/RGOASSYI6dandMdBhRV+OLC4CjNUdQJA2RHp1oApXMgDYXr3qqwOc5yKeR6nmjFADOCeOKQcZIqTFABxQBb0y4CP5bnhhSzukT5Y9OlUWOwAqOfaoZ5nkOW7UAN1G/zyCAfasppC333P0qO6kMk2R0HGKgedVVRkZBoAmcjkgHIqFnz1zVea55JB61TlvFRc7uaANB5dvJIqEz/MTkY+tZM2oA9zTIroE45H40Ab6SZXinB8msqGfOfmH41YjnGO3WgDWSd0ACn86tW98fuynj1rFSYe1SrKO5FAG4JreQgF+RU0+owou1cnjtXP8AmD/9VN84Hp+dAGjLqTAjG7rxk1Zg1QDln2t+hrDLjGSevSo2lIPpQB1Czw3HXajnowpZbeeIpJFj654Ncoly6klW5FX7PXpbfgtnPcdqANiW6laQrLHHMn8St1H0qhNZaXdkbDJBMT+FaFldWOoMNxEUpGGI6NTZdKeF9yISAfvDkUAZMmgXAy0EkdwBzwecVVaCaFsTRunsRXQRptYsMZ6ZPergkIAEmJBjoe1AHLoBjJ/WpBW5LYwXAJUGNu2OlZ9zYPbkbyCp9KAKg6GrEDMULE5xxioHGCRnpTUco3B470APuH3J79OawdVYgKMdK2bv7pAyeeMVzuruONxORQB5t4scG5l9K8yvP9e/1rv/ABRPzMzdOcV57OQzlu5NAFSSqsnWrUlVZOtAEMnUfWo+55qSSov4jQB+mcsZWMkcVkMnzFup71sklo2yR0qhJH8wxjmgDJnhwSwHy1X28E1szwEIS+AKz2GCe4NAFXHFBHp1qwVGe1QSsFYljQBXlOM8frWVqFwIUPI6VZvboRg8iuK8RamA4QsoHXrQBbnvlXJXv1rNkv13AZ4PPWucutYjDk7gwFY1zrjEnbtAPSgDrrrUzkAGqL3e4kk5NcodUkLHLcVLHflu4oA6ZZx6/rUqT/MuK51LrPOcVZiu+RyKAOmhmxj+tXIJh3IFc1Ddg4yauLcLuBBoA6JZvcVKsoLYrEjuVZfmI54FSpcjqWHFAGyJcHHA/GhJcjK9KyhdKDnqDS/alB64zQBoPKMZ6fSmNLlcZ+btms97kZ4NRtdD15oAuyykgY/SkWUVmG74PzDdSLd/7Q/GgDZR/myhIPtW5put3VqApkMqdwa5RLr0H61cguBkYb60Ad/DqlldgefGEbsVPQ1NKwVCUcOOxAriIJgMkEA1ftr2SMja+R6dqAOusmWUdgAP1rE1OcvKyAnCmn22oIUY8LJjp61lzzFnLE8k0APZt3Peq8rLlsntStMMHHNVZphtYt0xQBBPePErdxjoa5rW9QLKRtAPNat9MAhyee9cdrl1tViTgUAcR4rnwhGfvcYrjpRitnXLgz3JwcqvFYsjc4oArSGqsnWp5OpqtJ1NAEbVH3pzdajH3jQB+m8oKDleDxURUNyQa0Y2W4jwRVWeLyzjH0oAzrzjA7VQkUk9OvFaVypzVZ1oAz52EYwx5xWJfXOxWLvt4rQ1iUxhgOWxXEa1cs6sC3b1oAg1nWAqEJkn1rznVb97idnJ9q29anKRyYbOeK466kAQlj81AFW5uQq8msa61FUY7eabq8x8vBJGax+/egDTGpvuxtxU8Oqlex/Cssc0qjGaAN1NYBHzZBz6Vag1dDjJxXNYzTwMUAdlFqicYkzVuLU0GDvH51wyjHSpQTjqfzoA79NTTP3x+dWF1PIHzfrXnYdgmdx/OnJLIBkMwP1oA9GOpbgcMfzpv9p/wlv1rz37RL3dgPrSGZzx5h/OgD0FtUJwA3AqN9S968/aaRcjzGpn2mYDAkY/WgDvG1H3NNXUW3fe+WuBN1Op4c00Xc//AD0NAHpVtqW3HPetGLVMMOcV5Sup3adHzVmPXbpCM4P40AewWupBsFjwKvRaipBIbivH7bxKyth1bPXrWnB4qiONwI9aAPV474MoOTTzdY5z+decWnia2xgSY+pq+niG3IAMyn8aAO0a6C/Meap3F5kHJrlX16HHEqn33VnXXiGJFP7zJ9M0Ab2pX4Ab5q888R6oDujjOSetJquuy3G5YhtHc561zkzFnJY5JoAqSMWJzVOarMvX8apTdTQBBIcAmqznJqeXpVaSgCGbqKZTpOtR0AfpzYsY1+Q8H1q9J+8iPtRRQBn3EfHSqrLRRQBzHiAEOy4xxnNcHq7HnIFFFAHB67NhxHiuavT8p45oooA5vWGyVWs/vRRQBIOv4VIKKKAHj0FPoooAkQVMFwOaKKAAgYxil4UUUUAIMdKUdaKKABgGHSq7jniiigCKReegqP8ACiigBCMmiiigBacORjoaKKAHKpK9BTgCDzRRQA7kdCQKTb680UUAMkHFVZBg/WiigCnJ3qlKOtFFAFZ6rP0oooArSUyiigD/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rajvee Shah, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10830=[""].join("\n");
var outline_f10_36_10830=null;
var title_f10_36_10831="Mutilans in psoriasis x ray";
var content_f10_36_10831=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F58184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F58184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Arthritis mutilans in psoriatic arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radiograph demonstrating marked deformity and destruction of the hand digits in a patient with classic psoriatic arthritis and arthritis mutilans.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter H Schur, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_36_10831=[""].join("\n");
var outline_f10_36_10831=null;
